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Metazoans synthesize and regulate intracellular heme in a cell autonomous manner 
although genetic evidence in vertebrates suggests that cell non-autonomous 
mechanisms may exist at the organismal level. In C. elegans, a heme auxotroph, 
extraintestinal tissues are intrinsically dependent on the intestine, which acquires 
dietary heme for sustenance, supporting the concept that intestinal heme status must 
be coordinated at the systemic level to regulate whole-organism heme homeostasis. 
Here we show, by conducting a functional genome-wide RNAi screen in an 
intestinal-restricted heme sensor worm, that an interorgan heme signaling pathway 
exists and that >30% of the genes identified from the RNAi screen altered heme 
homeostasis in the intestine even though these genes are not expressed in the 
intestine. The biological basis for this signaling is underscored by HRG-7, a cathepsin 
protease-like protein secreted by the intestine and internalized by distally-located 
neurons.  HRG-7 is specifically secreted from the intestine during heme limitation 
and hrg-7 depletion causes embryonic lethality concomitant with a heme deficiency 
response.  Reciprocally, neuron-to-intestine heme signaling is mediated by the bone 
  
morphogenic protein homolog DBL-1, which recapitulates hrg-7 deficiency when 
depleted.  Remarkably, depletion of both genes simultaneously results in markedly 
enhanced growth and heme deficiency phenotypes, suggesting that bidirectional 
signaling between the intestine and neurons mediates systemic heme homeostasis.  
Our results have uncovered an unexpected role for a protease family member in long-
range communication between organs at the intestinal-neural axis to regulate systemic 
heme homeostasis in metazoa. As humans have over thirty cathepsin and cathepsin-
like proteases, several of which are secreted, we anticipate that these proteins may 
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Chapter 1: Introduction 
 
Heme homeostasis 
Heme is an iron-containing tetrapyrrole that is required as a cofactor for 
proteins involved in numerous cellular functions including hemoglobin for oxygen 
binding, cytochromes for electron transfer, and guanylate cyclase for cell signaling [1, 
2].  In humans, over sixty percent of iron in the body is heme-iron coordinated in 
hemoglobin.  Additionally, iron is more efficiently absorbed from the diet as heme-
iron [3-6].  However, despite its necessity free heme is also cytotoxic due to its 
inherent peroxidase reactivity and ability to produce reactive oxygen species [7-9].  
Moreover, heme is hydrophobic due to the porphyrin side chains and, a priori, cannot 
freely diffuse through the aqueous cytosol.  Therefore, cells must be able to carefully 
regulate heme levels, compartmentalization, and transport to target hemoproteins 
whilst preventing toxicity.  Although the regulatory processes of heme synthesis and 
degradation have been well characterized, other homeostatic mechanisms have 
remained elusive.  This is primarily due to the difficulty in uncoupling heme synthesis 
from downstream processes such as heme trafficking.  However, the discovery that 
the soil-dwelling nematode, C. elegans, contains hemoproteins but is unable to 
synthesize heme has led to the identification of several intracellular and intercellular 
heme transporters [10-13].  In C. elegans, all organismal heme must pass through the 
intestine before distribution to other tissues, and therefore it is not surprising that 
worms possess an intercellular transport system to mobilize heme from the intestine 




been presumed that in heme producing organisms such as mammals, heme synthesis 
and degradation function in a cell-autonomous manner and that is sufficient to 
maintain cellular heme levels without a need for an intercellular transport pathway.  
However, recent evidence suggests that such pathways do exist in vertebrates [14-17].  
The mechanisms of cellular heme homeostasis and evidence for intercellular heme 
transport in vertebrates will be discussed.    
 
Heme homeostasis in C. elegans 
The nematode C. elegans is a unique model in which to study systemic heme 
homeostasis.  Worms offer several general advantages as a model organism as they 
are genetically tractable, optically transparent, amenable for genetic screens and cell 
biological studies, and have a high percentage of genes that are conserved in humans 
[18].  More specifically and crucially for studying heme homeostasis, C. elegans is a 
heme auxotroph.  All heme that is utilized by the worm must pass through the 
intestinal brush border where it will be used directly by the intestine, stored for later 
use, or transported to extraintestinal tissues.  Heme destined for extraintestinal tissues 
must be transported through the intestinal epithelial cells and exported from the 
basolateral membrane to the pseudocoelom, the worm’s circulatory system.  Once in 
the pseudocoelom, extraintestinal tissues will have access to intestinal-derived heme.  
Using C. elegans as a model organism, these pathways can be studied without 
interference from confounding factors such as cellular iron transport and heme 
synthesis.  Based on transcriptomic analyses in C. elegans, several of the heme 




As the source of all heme in the worm, the intestine plays an essential role in 
organismal heme homeostasis, and thus expresses several genes necessary for 
adaptation to varying environmental heme availability.  As mentioned, all heme must 
pass through the intestinal brush border of the worm.  HRG-4 is a high-affinity heme 
permease involved in this process.  HRG-4 is specifically expressed in the C. elegans 
intestine at low heme and localizes to the apical intestinal membrane where it imports 
dietary heme [13, 19, 20].  RNAi knockdown of hrg-4 results in an intestinal heme 
deficiency signal, diminished intestinal accumulation of the fluorescent heme analog 
zinc mesoporphyrin (ZnMP), and protection from the toxic heme analog gallium 
protoporphyrin IX (GaPP) [20].  These data indicate that HRG-4 imports heme from 
the lumen into the intestine.  However, a genetic deletion of hrg-4 does not result in a 
growth phenotype, suggesting redundant pathways for heme uptake.  This redundancy 
is likely due to two HRG-4 paralogs, HRG-5 and HRG-6.  Unlike HRG-4, HRG-5 
and HRG-6 are not transcriptionally regulated by heme and therefore may mediate 
heme transport into the intestine in heme replete conditions when HRG-4 would 
normally be repressed.   Once in the intestine, at least a portion of heme will be 
compartmentalized into vesicles.  HRG-1, another paralog of HRG-4, is also 
upregulated by low heme specifically in the intestine but localizes to ZnMP-
containing intracellular vesicles.  RNAi depletion of hrg-1 results in vesicular ZnMP 
accumulation, suggesting that under heme limiting conditions, upregulation of HRG-
1 allows compartmentalized heme to be mobilized for utilization.  Interestingly, 
worms harboring mutations in both hrg-1 and hrg-4 exhibit a synthetic growth 




heme may be partitioned into separate labile and compartmentalized pools.  It is also 
possible that HRG-1 traffics via the apical plasma membrane and compensates for the 
lack of HRG-4 (Figure 1.1).   
Transport studies in Saccharomyces cerevisiae have identified the residues 
within these permeases that are important for heme transport [19].  HRG-4 transports 
heme by utilizing a histidine in the exoplasmic (E2) loop and a conserved FARKY 
motif near the C terminus.  Under low heme conditions when maximum transport 
activity is required, an additional tyrosine in TMD2 is necessary.  HRG-1, 
meanwhile, requires both a histidine in the predicted second transmembrane domain 
(TMD2) and the FARKY motif.  For optimal activity under heme-limiting conditions, 
HRG-1 requires a histidine in the E2 loop.  The presence of tyrosines rather than 
histidines in HRG-4 may help stabilize oxidized heme imported from the lumen [21, 
22].   
Interestingly, despite both genes being upregulated in the intestine by low 
heme, hrg-1 and hrg-4 appear to be transcriptionally regulated by different pathways.  
The heme-dependent regulation of hrg-1 is driven by a heme-responsive element 
(HERE) in conjunction with GATA sites, elements that bind the GATA transcription 
factor ELT-2 and are responsible for intestinal transcription in the worm [23, 24].  
Although the hrg-4 5’ flanking region also has GATA sites, it does not have a HERE, 







Figure 1.1: Model of heme homeostasis in C. elegans 
In order to adapt to varying environmental heme conditions, C. elegans has adopted 
several mechanisms to ensure that tissue heme requirements are fulfilled but heme 
toxicity is prevented.  In high environmental heme conditions, expression of high 
affinity heme transporters is repressed, and excess heme is compartmentalized in 
vesicles.  When the worm encounters low environmental heme, high affinity heme 
importers HRG-4 and HRG-1 are expressed to increase intestinal heme uptake and 
release heme stored in vesicles, respectively.  The heme exporter MRP-5 is slightly 
upregulated to facilitate heme availability to extraintestinal tissues.  HRG-3 is 
expressed to provide oocytes and developing embryos with sufficient heme, and 
genes such as HRG-2 in the hypodermis are upregulated in peripheral tissues to 
increase heme utilization.  It is likely that homeostatic adaptation is controlled at the 
systemic level by bidirectional signaling between the intestine and extraintestinal 






































Before heme can be utilized by extraintestinal tissues after uptake, it must be 
transported across the intestinal basolateral membrane.  Unlike the redundancy 
observed for heme importers, there appears to be one main intestinal heme exporter in 
the C. elegans intestine, MRP-5 (Figure 1.1).  MRP-5 is an ABC-transporter that 
localizes to the basolateral membrane and basolateral sorting vesicles of the C. 
elegans intestine.  Both a genetic deletion and RNAi depletion of MRP-5 result in 
embryonic lethality due to heme being trapped in the mother’s intestine, showing a 
lack of functional redundancy in intestinal heme export.  This lethality can be 
overcome by supplementing the worm growth medium with >200 µM heme.  In 
addition to embryonic lethality, depletion of MRP-5 leads to accumulation of ZnMP 
in the intestine and protection from GaPP, presumably by preventing it from being 
transported to extraintestinal tissues.  MRP-5 is also expressed in extraintestinal 
tissues such as the hypodermis, pharynx and some neurons, although it is unclear 
whether MRP-5 exports heme from these tissues or provides heme to hemoproteins in 
the secretory pathway, a function attributed to mammalian MRP5. 
Microarray and qRT-PCR data have shown that mrp-5 is upregulated by low 
heme, and bioinformatic analyses suggest that mrp-5, like hrg-1, has a conserved 
HERE and GATA cis-elements in the 5’ flanking region.  However, unlike hrg-1, 
mrp-5 continues to be expressed in high heme conditions, which is not surprising due 
to a lack of functional redundancy.  Unexpectedly, knockdown of mrp-5 results in a 
heme deficiency signal in the intestine despite also resulting in intestinal heme 
accumulation [12, 20].  This result suggests that when heme is trapped in the 




heme.  Thus it appears that though the intestine is the source of all heme in C. 
elegans, extraintestinal tissue have regulatory input over intestinal heme transport by 
regulating HRG-1 and possibly other transporters, indicating that heme homeostasis 
is maintained on an organismal level through intertissue communication (Figure 1.1).   
 While MRP-5 is required for embryonic survival over a broad range of heme 
concentrations, C. elegans has adapted an “emergency” mechanism at critically low 
heme conditions to ensure that oocytes developing within the germline receive the 
heme required for embryogenesis and larval development [11].  This is accomplished 
by upregulation of HRG-3, a 8.1 kDa heme chaperone that binds heme in a 2:1 
(protein: heme) stoichiometry, possibly through two conserved histidine residues 
[11].  Although hrg-3 is not detectable at heme concentrations greater than 6 µM, it is 
upregulated in the intestine more than 900 fold at 1.5 µM.  A genetic deletion of hrg-
3 results in embryonic lethality and L1 arrest, while chimeric HRG-3::mCherry is 
secreted from the intestine and localizes to developing oocytes.  Taken together, these 
data indicate that HRG-3 delivers maternal heme to developing oocytes.  It is unclear 
whether  HRG-3 acquires heme in the secretory pathway or in the pseudocoelom post 
secretion, or if heme loading is dependent on MRP-5.  Further analyses will be 
required to establish the relationship between different mechanisms of intestinal heme 
export.  Interestingly, HRG-3 is expressed in zygotes, all larval stages and in males, 
suggesting function beyond delivery of heme to the germline.       
In addition to HRGs in the intestine, we have characterized another heme-
responsive gene in the hypodermis termed hrg-2 [25].  HRG-2 is a single pass type I 




hypodermis.  In addition to the transmembrane domain, HRG-2 has a thioredoxin-like 
fold and a glutathione S-transferase-like domain on the carboxyl terminus.  Under 
heme limited conditions, hrg-2 is upregulated over 200 fold in the hypodermis.  A 
genetic deletion of hrg-2 results in an aberrant cytochrome heme profile, and ectopic 
expression of HRG-2 in a heme deficient strain of yeast facilitates growth in 
submicromolar concentrations of exogenous heme.  Together these data suggest that 
HRG-2 is involved in heme utilization in the hypodermis.  Although HRG-2 can bind 
heme, as a single pass membrane protein it is unlikely that HRG-2 itself is a heme 
transporter.  However, it may function as on oxidoreductase, which may facilitate 
heme uptake, similar to how DcytB and Steap3 facilitate iron uptake [26, 27].  
Circulating iron is in the Fe(III) oxidation state but is reduced during cellular uptake.  
A similar oxidation reduction pattern may exist for heme as it is transported between 
the cytoplasm, intracellular compartments, and extracellular space.   
The characterization of heme-responsive genes demonstrates that C. elegans 
has adapted several mechanisms to cope with varying environmental heme 
availability.  However, heme homeostasis is intrinsically linked to metabolism due to 
the requirement of heme for respiration amongst other metabolic processes.  
Therefore, cellular heme requirements will vary according to metabolic fluctuations 
independent of environmental heme availability.  One such regulator of metabolism is 
circadian rhythm [28].  In. C elegans, temperature fluctuations are one of the 
environmental cues that drive circadian rhythm.  Many heme-responsive genes, 
including all the genes discussed above, are transcriptionally regulated during 




by circadian rhythm [29].  In mammals there is a reciprocal relationship between 
circadian rhythm and heme homeostasis.  Two transcription factors involved in 
mammalian circadian rhythm, Rev-erb alpha and Per2, are regulated by bound heme 
[30, 31].  In return, the circadian clock controls heme levels through NPAS-
2/BMAL1, a core clock component complex, which regulates expression of the first 
enzyme in the heme biosynthetic pathway, ALAS1.  [32].  How such metabolic 
fluctuations are influenced and integrated with heme availability in C. elegans has yet 
to be elucidated. 
It is interesting that the worm has adopted several transcriptional pathways for 
the upregulation of intestinal genes in low heme.  We speculate that each pathway is 
specific to a particular response.  For example, while mrp-5 depletion results in 
upregulation of hrg-1 through the HERE, hrg-3 is downregulated, suggesting that the 
HERE is predominately regulated by extraintestinal signals while the regulation of 
the hrg-3 promoter is dominated by intestinal heme status.  In this model, as hrg-1 
and mrp-5 both have a HERE, heme mobilization from storage vesicles in the 
intestine would be released to the extraintestinal tissues for general usage as an initial 
heme deficiency response, but the directed delivery of heme to embryos would not 
occur until intestinal heme stores were sufficiently low.  These different mechanisms 
would enable tight control over systemic heme homeostasis and possibly establish a 
hierarchy of tissue heme distribution under heme limiting conditions.  In support of 
this postulation, RNAi knockdown of mrp-5 or hrg-4 results in upregulation of hrg-1, 
but only knockdown of mrp-5 results in upregulation of hrg-2.  This suggests that the 




genes in extraintestinal tissues, which are only turned on once systemic heme 
availability is low.  The “sensors”, transcription factors or otherwise, that sense and 
initiate a response to varying heme conditions in each tissue have yet to be elucidated.  
Uncovering how each tissue senses and communicates heme levels will be crucial to 
understanding organismal heme homeostasis.  
 
Heme homeostasis in mammals 
In mammals, different tissue types have vastly different heme requirements.  
Erythrocytes have the highest heme requirement and highest synthesis rate due to 
hemoglobin production [2].  Adult humans have about 25 trillion red blood cells 
(RBCs), and each second we recycle about 5 million RBCs by erythrophagocytosis 
(EP) in macrophages of the reticuloendothelial system [6].  Therefore, heme synthesis 
and degradation must be highly regulated processes that are coordinated between, but 
also differ in, various cell types.  To date, synthesis is the most thoroughly 
characterized mechanism of regulating cellular heme levels, with most regulatory 
differences found between red blood cells and other tissues.  
 
Intracellular heme homeostasis     
In most eukaryotes and prokaryotes, heme is synthesized via a conserved 
eight-step pathway.  In eukaryotes, the first and last three reactions take place in the 
mitochondria, while the remainder of the reactions occurs in the cytosol.  Disruptions 
to the heme synthesis pathway can result in the porphyrias, or the toxic accumulation 




aminolevulinic acid synthase (ALAS), which synthesizes 5-aminolevulinic acid 
(ALA) from glycine and succinyl-coenzyme A (succinyl-CoA).  The human genome 
encodes two ALAS genes; ALAS1 is ubiquitously expressed whereas ALAS2 is red 
blood cell specific. At the transcriptional level, ALAS2 is upregulated during 
erythropoiesis through the binding of erythroid-specific transcription factors, such as 
GATA-1 and NF-E1, to their target sequences in the ALAS2 promoter [33].  
Interestingly, while ALAS1 is negatively regulated by heme, ALAS2 is not, which may 
be expected due to the high demand of heme for hemoglobin production in red blood 
cells.  Rather, ALAS2 is regulated post-transcriptionally by iron to prevent the 
accumulation of toxic heme intermediates when there is insufficient iron for heme 
synthesis [34]. The ALAS2 transcript contains an iron response element (IRE) in the 
5’ untranslated region (UTR) which is regulated by the iron regulatory protein (IRP) 
when under iron deplete conditions, thereby blocking ALAS2 translation.  Sufficient 
iron results in IRP dissociation from the ALAS2 5’ UTR to allow translation.  Post-
transcriptional regulation of ALAS2 enables erythroid cells to couple heme synthesis 
with iron availability with more immediate effect than regulation at the transcriptional 
level.  
The second, third, and fourth genes in the heme biosynthetic pathway, ALAD, 
PBGD, and UROS, all achieve higher expression in erythroid cells compared to other 
tissues due to erythroid specific promoters [35, 36].  The erythroid specific promoters 
of ALAD and UROS bind the erythroid specific transcription factor GATA-1, while 




genes, UROD, CPOX, PPOX, and FECH all have higher expression in erythroid cells 
compared to other tissues independent of tissue specific promoters [37-39].    
In addition to synthesis, cellular heme levels are mediated by heme oxygenase 
1 (HO-1) and heme oxygenase 2 (HO-2) which degrade heme into iron, CO, and 
biliverdin.  Heme itself is a regulator of HO-1 through the heme-binding 
transcriptional repressor Bach1 [40].  Bach1 heterodimerizes with small Maf proteins 
to bind MAf Recognition Element (MARE) sequences and repress transcription.  
MARE sequences are present in the Hmox1 promoter.  In high heme conditions, heme 
binds Bach1 through four cysteine proline (CP) heme regulatory motifs, resulting in 
Bach1 transport out of the nucleus, followed by degradation [40-42].  This will result 
in the Maf proteins forming new heterodimers with p45, the large subunit of the 
erythroid-specific transcription factor NF-E2.  This heterodimer acts as an activator 
when bound to the MARE.  Therefore, Bach1 mediated repression only occurs in low 
heme conditions.  When heme levels are high, negative feedback allows derepression 
of the MARE and upregulation of HO-1 to degrade excess heme.  In addition to HO-
1, the locus control region (LCR) of hemoglobin has MARE elements, thereby 
coupling heme levels to globin chain production [43]. 
 Heme can be regulated not only by cellular levels but by sequestration and 
transport into and out of vesicles.  After EP of senescent erythrocytes by 
macrophages, heme transport out of the phagolysosome for degradation by HO-1 is 
mediated by HRG1 [44].  HRG1 localizes to the phagolysosome and depletion of hrg-
1 by siRNA results in lower mRNA expression of Hmox1, Fpn1, and reduction in 




Interestingly, macrophages also express two heme exporters, FLVCR1 and MRP5.  
This suggests the possibility that a pool of heme transported by HRG1 out of the 
phagolysome is exported in toto out of the macrophage.  HRG1 itself is upregulated 
by cellular heme, which may in part be Bach1 dependent [45].   In addition to 
macrophages, HRG1 is expressed in brain, heart, kidney, muscle, placenta and 
intestine, suggesting a role for HRG1 beyond heme transport out of phagolysosomes 
[13].  Accordingly, in zebrafish morpholino knockdown of hrg1 results in anemia, 
hydrocephalus, and a curved body with shortened yolk tube.  Remarkably these 
phenotypes can be rescued with C. elegans HRG1 despite the two proteins sharing 
only 20% identity.  This demonstrates that conserved mechanisms of heme 
homeostasis exist between the heme auxotroph C. elegans and vertebrates that 
synthesize heme.   
Correspondingly, zebrafish MRP5 is essential for normal morphology and 
hemoglobinization of red blood cells [12].  In mammalian cells MRP5 localizes to 
both the plasma membrane and to endosomal compartments where it appears to 
facilitate incorporation of heme into hemoproteins in the secretory pathway.  
Therefore, in addition to its role in cellular heme export, MRP5 may transport heme 
from the cytosol to the secretory pathway.    
   In conjunction with synthesis, degradation, and compartmentalization, cells 
may be able to regulate heme levels by efflux.  Another heme exporter, FLVCR1, has 
been described which belongs to the major facilitator superfamily. FLVCR1, unlike 
MRP5, only localizes to the plasma membrane and mediates efflux of ZnMP from rat 




shown to be required for erythropoiesis.  However, this is likely due to a second, 
mitochondrial isoform of FLVCR1 (FLVCR1B) which controls mitochondrial heme 
efflux.  Due to an alternative start site, FLVCR1B has a shortened amino terminus 
with a mitochondrial localization signal [47].  Specific silencing of Flvcr1b resulted 
in termination of erythroid differentiation, while silencing the plasma membrane 
isoform, Flvcr1a, did not affect erythropoiesis but still lead to hemorrhage, edema, 
and skeletal abnormalities.    
   
Intercellular heme homeostasis 
Free heme and heme complexed to hemoglobin is released from mammalian 
cells into the blood stream in response to disease, inflammation, or intravascular red 
blood cell hemolysis.  Two serum proteins, both related to proteases, have been 
identified that scavenge heme and hemoglobin to preserve iron and inhibit oxidative 
stress caused by extracellular heme.  Haptoglobin, which is related to S1 proteases 
and is secreted mainly by hepatocytes, binds free hemoglobin in the plasma with a Kd 
≈ 10
−12
 M [48, 49].  The haptoglobin-hemoglobin complex is bound by the receptor 
CD163 and endocytosed by tissue macrophages [50]. The macrophages subsequently 
degrade the heme to release iron, which will be reutilized by erythroid cells for 
hemoglobin production [51, 52].  
Hemopexin, which is related to matrix metalloproteases and also produced 
predominately by the liver, binds free heme in the plasma with a Kd ≈ 10
−13
 [53].    
The hemopexin-heme complex is bound by the LRP1 (CD91) receptor, which is 




syncytiotrophoblast, and neurons [54]. When the hemopexin / CD91 complex is 
endocytosed by the liver, heme is removed and the rest of the complex is recycled 
[53, 55].  Interestingly, hemopexin has been shown to directly bind FLVCR1 and the 
presence of hemopexin in cell culture media increased heme export by macrophages 
more than 100 fold. [16].  Furthermore, cell cultures studies have shown that a 
portion of heme obtained by macrophages after erythrophagocytosis is transported out 
of the cell intact [56].  Based on this data, it is possible that hemopexin facilitates the 
delivery of heme in toto from macrophages to the liver.  The liver itself has 
mechanisms for heme import, as patients with acute porphyria who are administered 
intravenous heme complexed to albumin show increased heme-dependent enzyme 
activity in the liver [57].       
Recently, Haldar et. al showed that during hemolysis, heme from senescent 
red blood cells serves as a signal for monocytes to differentiate into macrophages 
through regulation of SPI-C [17].  The transcription factor SPI-C is expressed in 
splenic red pulp macrophages and is required for their development. The heme-
induced expression of Spic is through derepression of Bach1, indicating that heme 
from erythrocytes must be transported into the nucleus of monocytes.  These results 
predict that a portion of heme that crosses the phagolysosomal membrane after EP is 
not immediately degraded by heme oxygenase but must remain intact for function, 
implicating that the intertissue transport of heme is essential for cellular 
differentiation.      
In addition to macrophage EP of red blood cells, another major source of 




enterocytes and utilized for iron, evidence exists that some heme may be directly 
exported from the intestinal basolateral membrane [58-60].  Interestingly, studies in 
Caco2 cells have demonstrated that a portion of heme remains intact and is 
transported from the basolateral membrane out of the cell [61].  Therefore, a 
percentage of dietary heme may be distributed to peripheral tissues intact. 
Similar to HRG-3 in C. elegans, there may be specific pathways for maternal 
fetal heme transfer in vertebrates.  Zebrafish defective in heme synthesis survive 10-
25 days post-fertilization [62].  Due to the high energy demands of a developing 
embryo, this suggests a possible maternal heme contribution.  Along these lines, 
FLVCR1 expression in human placenta is correlated with LRP1 expression and 
neonatal iron status.  Moreover, HRG-1 is expressed in the placenta [13].  Therefore, 
the placenta expresses the necessary transporters for heme import from maternal 
blood and heme export to the fetus, which may become a significant source of iron 
during development [15, 16]. 
There is also evidence for heme uptake in neurons.  Neurons require heme for 
respiration, growth, and differentiation, and both heme depletion and accumulation 
have been linked to neurodegeneration [63].  Therefore neuronal heme levels must be 
tightly controlled, and evidence suggests that this may in be part accomplished 
through intertissue heme transfer.  In chicken dorsal root ganglion cultures treated 
with ALA, only the Schwann cells and macrophages showed fluorescence from heme 
biosynthesis intermediates despite all three cell types taking up ALA, suggesting the 
heme synthesis pathway in neurons was less active [64].  Due to their high 




it is unlikely that neurons simply require less heme.  Additionally, premature 
senescence of heme depleted neurons can be rescued by exogenous heme, and they 
can endocytose hemopexin-heme complexes, indicating that neurons can import heme 
[65-67].  Interestingly, the brain itself expresses hemopexin and FLVCR1, and 
depletion of hrg1 in zebrafish embryos results in a defect in hindbrain-midbrain 
formation [13, 46, 68]    These results hint at the intriguing possibility that neurons 
may in part regulate heme levels by intertissue trafficking.              
Taken together, these studies indicate that intertissue heme transport may not 
just be limited to obligate heme auxotrophs.  However, more research is required to 
understand to what extent heme transfer between cells is required compared to iron 
transfer for cell-autonomous heme synthesis. Direct heme transfer between cells may 
become more relevant under specific conditions, such as low iron availability or 
pathogenesis. 
   
The brain – gut axis 
The bilateral communication between the central nervous system and the 
gastrointestinal system, referred to as the brain-gut axis, plays a key role in metazoan 
homeostasis.  In mammals, both sugar and lipid sensing in the gut, through 
enteroendocrine cells (EECs) and I cells, can stimulate the central nervous system 
through neuropeptides and peptide hormones [69-71].  Direct neuronal connections 
are also maintained between central nervous system and the enteric nervous system 
through the vagus nerve.  The close relationship between nervous system and gut is 
conserved across phyla.  Carbohydrate homeostasis in Drosophila involves brain 




development, and stress are all regulated on a systemic level through communication 
between the nervous system and intestine [72-76].  Furthermore, the C. elegans 
intestine has endocrine function and has been shown to directly communicate with the 
nervous system via a secreted neuropeptide to regulate the defecation cycle [77].  The 
enteric nervous system and communication between the intestine and brain will be 
discussed in further detail below.     
 
The enteric nervous system 
In the early twentieth century, Byron Robinson, MD, described a second brain 
in the abdomen which he believed was just as important as the cranial brain [78].  
Robinson hypothesized that the abdominal brain presided over nutrition and was in 
fact the center of life itself.  Today we refer to this “second brain” as the enteric 
nervous system (ENS).  The ENS is found throughout the animal kingdom, including 
invertebrates such as insects and mollusks [79].  In fact, it has been hypothesized that 
the ganglia which compose the primitive brain of helminths evolved from gut circuits 
[69].  The ENS is derived from neural crest cells and is composed of about 100 
million neurons, or about as many as the spinal cord, that are divided into eighteen 
functional classes [80].  It is arranged into two concentric plexuses, the outer 
myenteric, or Auberbachs plexus, and the inner submucosal, or Meissner’s plexus. 
The ENS receives mechanical and chemical information from the gut lumen via 
intrinsic primary afferent neurons (IPANS) that innervate the intestine, and functions 
such as intestinal motility, absorption, secretion, and blood flow are carried out by efferent 




especially the hypothalamus and the nucleus tractus solitarii (NTS), are maintained 
through the vagus nerve, the ENS continues to function when this nerve is severed, 
indicating that the ENS can function autonomously [81, 82].   
Neuropathology of the ENS usually results in impaired gut function [80].  The 
most recognized neuropathy is Hirschsprung’s disease (HSCR), which is a congenital 
disorder resulting from the absence of ganglia [83].  Several genes have been 
implicated in HSCR, including RET and EDNRB, which are both involved in neural 
crest cell migration [84].  Another gene involved in the development of the ENS, 
neuregulin 3 of the epidermal growth factor (EGF) family, has also been implicated 
in HSCR [85].  It has also been suggested that the pathology associated with 
enterocolitis and Crohn’s disease, an immune disease, may develop in part due to loss 
of glial cells associated with the ENS.  Of note, dominant neurovisceral porphyrias 
can be inherited with HSCR and other ENS pathologies [86, 87].  Similarly, carbon 
monoxide signaling impairment due to a lack of HO-2 has also been linked HSCR 
[88, 89].  These studies indicate there is an interconnection between heme metabolism 
and ENS function which warrants further investigation.            
 
Gut to Brain signaling 
As the largest interface between the environment and our bodies, the 
gastrointestinal tract has an integral role in homeostasis and must be able to 
communicate with the master regulator, the central nervous system.  Additionally, the 
gut has by far the largest population of commensal organisms of all the body surfaces, 




gastrointestinal tract [90].  It is becoming clear how important these microorganisms 
are in the function of the brain-gut axis [91].  Accordingly, two thirds of the body’s 
immune cells are found within the gut.  Moreover, the gut has thousands of endocrine 
cells that produce at least 20 different hormones.  The gut can communicate with the 
brain through three main mechanisms: through the nervous system, through immune 
cells, and through EECs.    
 Signaling from the gut to the brain through the nervous system begins with 
intrinsic primary afferent neurons.  These neurons do not receive luminal signals 
directly but from endocrine or immune cells [92].  Extrinsic afferent neurons from the 
vagus nerve and spinal cord also have connections in the gut.  Specific populations of 
these extrinsic primary afferents synapse with dorsal horn neurons in the spinal dorsal 
horn or with cell bodies in the vagal NTS.  These connections provide the brain with 
a wide range of gut-related information.  While most intestinal function is regulated 
by IPAN and efferent motor neuron reflex loops within the ENS, gastric function is 
mediated through vagal reflexes.          
Endocrine cells in the gut constitute the largest endocrine organ in the body.  
As previously mentioned, endocrine signaling can function through the ENS.  
However, signals initiated from EECs can also directly communicate to vagal 
afferents and to the hypothalamus.  Activation of EECs can take place through several 
mechanisms, including mechanosensitive cation channels and various macronutrient 
receptors.  In fact, several nutrient receptors that are expressed on the tongue are also 
expressed in the intestinal EECs, including the sugar receptors T1R2 /TR13.  When 




the brain (hypothalamus) and pancreas, resulting in altered feeding behavior and 
increased insulin secretion [76].  Here, environmental probing by the gut results in 
systemic sugar homeostasis through the coordination of endocrine and nervous 
system signaling.   
 The enteric immune system is presented with a unique challenge:  Tolerance 
of commensal bacteria but response to pathogens [93].  It is thought that commensal 
bacteria are recognized by EICs and don’t elicit an immune response.  When 
pathogens are encountered, microfold cells deliver antigens, through transcytosis, to 
antigen processing cells within Peyer’s patches to elicit an immune response.  Vagal 
afferents located near EICs respond to several signaling factors, including proteases, 
histamine, serotonin and corticotropin releasing factor [94].  Remarkably, gut 
microbiota may play an integral role in neurodevelopment, especially during 
childhood and adolescence [95].  Perturbations of microbiota during these time 
periods have the potential to disrupt the brain-gut axis and increase the risk of 
neurological disorders.  In addition to the immune response and signaling to the 
nervous system, immune cells can also influence EEC function.   
 
Brain to gut signaling 
The brain can communicate with the viscera through parallel pathways, including the 
autonomic nervous system (ANS) and the hypothalamus (Figure 1.2) [69].  Although 
the ANS input is triggered by reflexes originating from the ENS, it can be overridden 
by the central nervous system [96, 97].  Prolonged alterations to the ANS may results 




Figure 1.2: Reflex circuits of the brain-gut axis 
Both top-down (brain to gut) and bottom up (gut to brain) environmentally stimulated 
responses optimize homeostatic regulation of intestinal function. Blue boxes are 
neuron types, yellow boxes are location.  Anterior cingulate cortex (ACC), nucleus 
tractus solitarius (NTS), dorsal motor nucleus of vagus (DMNV). The NTS and 
DMNV make up the dorsal vagal complex (DVC). A1, A2 and A5 are medullary 
catecholaminergic nuclei to autonomic effector regions in the rostro–ventro–lateral 
medulla (RVLM) and ventromedial medulla (VMM). Periaqueductal grey (PAG), 
prefrontal cortex (PFC), the insula (INS), autonomic nervous system (ANS).  Image 










































the sympathetic and parasympathetic divisions of the ANS provide feedback to the 
gut.  The overall effect of sympathetic signaling to the gut is inhibitory, slowing 
transit and secretion.  In addition to modulating endocrine and motor function, 
another subset of sympathetic postganglionic neurons are involved in mucosal 
immune modulation, including modulation of Peyer’s patches.  Parasympathetic 
innervation of the gastrointestinal tract includes vagal and sacral division, and, as 
mentioned previously the vagal input is crucial for gastric function through both 
motor neurons and endocrine cells.  Top-down engagement from both sympathetic 
and parasympathetic postganglionic neurons influence emotion-related changes in 
motor, secretory and immune activity in the gastrointestinal tract [97]. 
Much of the focus on CNS control of nutrient homeostasis has been on satiety 
in response to signals such as leptin, ghrelin, insulin, peptide YY, cholecystokinin, 
and GLP-1 from the viscera [98, 99].  The hypothalamus, which receives both neural 
and endocrine signals, is particularly important to the satiety response.  Feedback 
from the viscera initiates a neurotransmitter cascade within the hypothalamus.  The 
cascade begins with neurons that produce neuropeptide Y (NPY) or agouti-related 
peptide (AgRP) and ends with neurons producing appetite stimulating neuropeptides 
melanin concentrating hormone (MCH) and orexin or the appetite suppressing 
neuropeptide corticotropin releasing hormone (CRH) to alter feeding behavior [100].        
 
Proteases 
A protease is an enzyme that can disrupt the peptide bond between amino 




protease homologs, which can be grouped into four broad classes based on the 
catalytic residues of the active site: serine/threonine proteases, metalloproteases, 
aspartic acid proteases, and cysteine proteases (Figure 1.3) [101].  Some organisms 
also express asparagine and glutamic acid proteases. 
Proteases are involved in a wide array of functions, ranging from general 
turnover to signaling through activation of a specific substrate.  They are often 
synthesized as zymogens which require propeptide removal before becoming active.  
Many also have a signal peptide for entry into the secretory pathway upon translation.  
The four major classes of proteases will be discussed, as will protease signaling and 
proteases in parasitic organisms.   
 
Classes of proteases 
Mammalian aspartic proteases can be divided into two clans: AA (families A1, A2, 
A28, A33) and AD (family A22).  The A1 family has been the most extensively 
studied and includes pepsin, renin, cathepsin D and cathepsin E.  Most studies of the 
A22 family have focused on prenesilin, due to its purported role in familial 
Alzheimer’s disease [103].  Aspartic acid proteases utilize a catalytic dyad of two 
aspartic acids for proteolysis, and are typically active at low pH.  In general, low pH 
induces activation through autocatalysis of the propeptide.  Examples of 
autoactivation include pepsin in the stomach and cathepsin D in the lysosome.  A 
notable exception is renin, which requires trans-activation by another protease.  Many 
aspartic acid proteases are secreted, however cathepsin D is mainly lysosomal; 




Figure 1.3: The active sites of the four major classes of proteases 
A) Serine proteases use a catalytic triad of histidine, serine and aspartic acid. The 
histidine, with the aid of the proton-withdrawing aspartate, deprotonates the serine 
hydroxyl, enabling nucleophilic attack on the substrate carbonyl carbon. B) Cysteine 
proteases employ a similar mechanism as serine proteases, but the nucleophile is the 
sulphur atom of a cysteine residue. C) Aspartic proteases utilize two aspartic acid 
residues that act in a general acid–base mechanism. A water molecule coordinated 
between the aspartic acids is activated by the abstraction of a proton, enabling the 
polarized water to attack the carbonyl carbon of the substrate's scissile bond. D) 
Metalloproteases utilize a coordinated metal, typically zinc, in their catalytic 
mechanism. In many soluble metalloproteases, such as thermolysin and the matrix 
metalloproteases, coordination is accomplished by three histidines, or two histidines 
and an acidic side chain. A water molecule serving as an additional zinc ligand is 
hydrogen-bonded to a glutamate, which abstracts a proton from the attacking water 
molecule. Red arrows indicate movement of electron pairs. Blue dotted lines 
represent hydrogen bonds or other electrostatic interactions. Grey lines represent the 
continuation of the substrate polypeptide to either side of the peptide bond that is 






































the plasma membrane depending on cell type; and presenilin is membrane-bound 
[104-106].  The active site specificity of these proteases can vary depending on 
function.  Pepsin and cathepsin D, which are involved in digestion and protein 
turnover, respectively, require broad specificity due to the variety of substrates 
encountered [107].  Renin, in contrast, is involved specifically in regulation of  
systemic blood pressure, and is only known to cleave angiotensinogen at a single 
leucine- valine bond [108].   
Mammals have several families of cysteine proteases, with the most 
extensively studied being the cathepsins (family C1) and calpains (family C2) of clan 
CA and the caspases (family C14) of clan CD.  Cysteine proteases use a catalytic 
dyad of a cysteine and histidine residue for proteolysis.  
Caspases have been studied in detail due to their key role in apoptosis.  As 
mediators of cell death, they lack a signal peptide and are not translocated to the 
secretory pathway, but rather members are present in the cytosol, mitochondria, and 
nucleus [109].  They can be divided into two classes: initiator caspases and effector 
caspases.  Initiator caspases are activated by increased mitochondrial permeability, 
TNF alpha signaling from macrophages, and Fas signaling from T lymphocytes [110, 
111].  Once activated, initiator caspases activate effector caspases by catalytic 
removal of effector propeptides.   Subsequently, effector caspases then cleave effector 
proteins such as lamins, which will result in apoptotic cell death.   
The majority of cathepsins are C1 proteases, with include cathepsin B, 
cathepsin L, and cathepsin K.  There are two known types of endogenous inhibitors of 




(CTLA-2), which allow the regulation of activated proteases.  Cathepsin K, a secreted 
cathepsin, plays a critical role in bone resorption under calcium limiting-conditions 
[112].  Cathepsin L was traditionally thought be to be involved in general protein 
turnover within the lysosome, although it may also have more specific roles such as 
neuropeptide processing [113].  Cathepsin B is unique in that it can serve as both an 
endopeptidase and peptidyldipeptidase peptidase (removal of a carboxyl terminal 
dipeptide), which is attributed to the presence of a 20 amino acid insert called the 
occluding loop [114].  It has been suggested that the occluding loop blocks the active 
site of cathepsin B at low pH, resulting in the enzyme now functioning as a 
dipeptidase.  However, at basic or neutral pH, the loop is displaced, resulting in 
cathepsin B functioning as an endopeptidase [115].  Cathepsin B usually resides in 
the acidic lysosome, suggesting that it functions primarily as a dipeptidase.  In 
support of this, cathepsin B knockout mice do not have protein turnover defects, 
although this is likely, at least in part, due to functional redundancies with other 
proteases [116].   
The calpains are a family of calcium-dependent proteases that are mainly 
resident in the cytosol, and therefore, like caspases, do not have signal peptides.  They 
are not involved in degradation but selectively respond to calcium signaling.  An 
example is the cleavage of cytoskeletal proteins to facilitate cell migration [117, 118].  
  Serine proteases play pivotal roles in many mammalian processes, including 
blood coagulation and digestion.  Serine proteases typically have a catalytic triad 
consisting of a serine, histidine, and aspartic acid.  The majority of serine proteases in 




proteases [107].  Members include trypsin, cathepsin G, and the membrane-bound 
matriptases.  Many S1 proteases are secreted and thus have a signal peptide on the 
amino terminus, followed by a propeptide, or amino terminal extension.  In blood 
coagulation proteases such as plasmin and thrombin, the amino terminal extension 
contains other domains, including Kringle domains, which are important for 
mediating the protein-protein interactions between blood coagulation factors [119].  
Activation of these proteases requires cleavage of the amino terminal extension, 
which nonetheless remains bound via disulfide bridges serving as the heavy chain 
subunit of the protease [120].  The exposure of the new amino terminus after cleavage 
initiates a structural rearrangement, in which the newly exposed amino terminus binds 
to the aspartic acid within the active site.  Endogenous serpins inhibit S1 proteases.  
Other notable serine proteases include signal peptidase (family S26), furin (family 
S8), the rhomboid proteases (family S54), and serine carboxypeptidase A, also called 
cathepsin A (family S10).           
Metalloproteases are the most diverse class of proteases.  Most of these 
proteases utilize a zinc ion coordinated by two or three histidines and a glutamic acid 
in the active site.  Cobalt is occasionally used instead of zinc.  Metalloproteases are 
placed in groups according to the primary structure of their catalytic sites and include 
the gluzincins, metzincins, inuzincins, carboxypeptidases, and DD carboxypeptidases 
[121].  The metzincin subgroup (mainly clan MA) is further divided into serralysins 
(family M10), astacins and adamalysins (family M12), and matrixins (family M10) 
[122].  The latter two families have been the described in detail as they comprise the 




function as sheddases, cleaving cell membrane proteins for signaling and turnover 
[123].  MMPs are involved in matrix remodeling through cleavage of extracellular 
matrix proteins, but function in other processes as well [124].  Both of these families 
utilize three histidines for zinc coordination and a catalytic glutamic acid.  In addition 
to the metalloprotease domain, ADAM family members have EGF domains, cysteine 
rich domains, and disintegrin domains which likely assist in substrate specificity and 
activity [125]. MMPs have fibronectin II-like and hemopexin-like domains, which 
may help these proteins bind to the extracellular matrix. 
 
Protease signaling 
     Although once assumed to be mainly involved in general protein turnover, 
it is becoming clear that proteases are essential for a number of biological processes, 
including a crucial role in cell signaling.  Each of the main classes of proteases have 
active members or related pseudoproteases that are involved in cell signaling.  Their 
role in signaling varies from receptor processing to acting directly as a ligand.  
Protease signaling often involves cascades involving multiple cleavages of a single 
substrate, or proteases that act as substrates for each other, providing added levels of 
regulation [126].  Protease signaling mediates several essential physiological 
processes, including blood pressure, iron homeostasis, and the inflammatory 
response, which will be discussed below.    
 Serine proteases have an abundant and diverse role in protease and 
pseudoprotease signaling in mammals.  Furin is a convertase responsible for 




signaling ligands such as TGFβ and parathyroid hormone, but also other proteases 
which can in turn effect signaling [127].  One target of furin is TACE, or ADAM 
metalloprotease-17.  Furin processing of TACE occurs in the Golgi apparatus, and 
then TACE traffics to the plasma membrane where it facilitates TNFα shedding to 
initiate an inflammatory response [128].  Remarkably, TACE trafficking from the ER 
to Golgi requires chaperone activity from a proteolytically inactive rhomboid protease 
homolog, or pseudoprotease, iRhomb2 [129].  In the absence of iRhomb2, TACE 
remains as a zymogen trapped in the ER, ultimately resulting in failure to promote 
inflammation.  This singular signaling event requires the coordinated actions of a 
metalloprotease, a serine protease, and a serine pseudoprotease.  TACE is also 
involved in Notch signaling, although the requirement for iRhomb2 has not been 
established [130]. 
 Systemic iron homeostasis is regulated by the hormone hepcidin, which is 
secreted from the liver when high iron is sensed.  Hepcidin binds to ferroportin on the 
basolateral membrane of the intestine, liver and macrophages, leading to ferroportin 
degradation and less circulating iron.  Hepcidin is positively regulated by BMP6 
signaling through an iron specific BMP co-receptor called hemojuvelin.  In low iron, 
a serine protease called TMPRSS6 (matriptase-2) is upregulated and degrades 
hemojuvelin, resulting in less BMP signaling and ultimately less hepcidin production, 
thereby allowing more iron release into circulation [131].     
One of the most extensively studied examples of protease signaling is 
regulation of the renin-angiotensin system (RAS) by the aspartic acid protease renin.  




renin secretion from the kidney [132].  Renin activation requires a trans-acting 
protease, and although the cysteine protease cathepsin B has been implicated in this 
process, this remains controversial [133, 134].  Circulating, active renin cleaves 
angiotensinogen, an α-2 globulin that functions as a hormone, secreted by the liver to 
produce angiotensin I.  A second cleavage event by the protease angiotensin-
converting-enzyme (ACE), results in active angiotensin II.  Through the angiotensin 
II receptors, which are G-coupled protein receptors, angiotensin II induces changes in 
adipose, cardiac, central nervous system, adrenal gland, and kidney function to 
regulate systemic blood pressure [135-137].  In addition to blood pressure regulation 
through angiotensin, a (pro)renin receptor, the first receptor identified for an aspartic 
protease, has been described.  The (pro)renin receptor binds pro-renin at the cell 
surface, resulting in active renin through a conformational change.  Pro-renin or renin 
binding also induces activation of MAP kinases ERK1 and ERK2 [138].  However, 
this receptor has also been implicated in WNT signaling and vacuolar ATPase 
activity, and there is still much debate about its actual physiological role [139].   
In addition to modulating signaling indirectly through regulation of ligands 
and receptors, proteases and pseudoproteases can act directly as receptor ligands.  An 
example is S1 serine protease signaling through the protease activated receptors 
(PARs).  PARs are G-coupled receptors that when activated, result in several 
downstream functions such as platelet aggregation, cell growth and division, and 
neuron survival [140].  PARs are unique in that rather than activation through ligand 
binding, activation occurs through processing of an exoplasmic amino terminus by 




four PARs (PAR1-PAR4).  PAR1, -3, and -4 are activated by thrombin, while PAR-2 
is primarily activated by trypsin [141].  PAR4 can also be activated by trypsin and 
cathepsin G.  The cleavage of PARs at various peptide bonds by different proteases 
allows biased signaling in a context specific manner.           
 
Pseudoproteases 
  It is becoming apparent that pseudoproteases play an important biological 
role. Two well described signaling ligands, hepatocyte growth factor (HGF) and sonic 
hedgehog (Shh), are pseudoproteases.  HGF signaling is initiated when HGF binds 
the tyrosine kinase receptor Met, which results in processes such as cell proliferation 
and motility [142].  HGF is an S1 family pseudoprotease.  Like plasmin, HGF has 
Kringle domains in the propeptide which is cleaved but remains attached to the light 
chain by disulfide bridges [142].  This processing is necessary for signaling.  
Although not a protease, the active site pocket is required for function.  Perhaps 
telling, the aspartic acid, which is necessary for active serine proteases to undergo a 
conformational change, is conserved.  Shh signaling is another example of a 
pseudoprotease functioning as a receptor ligand.  Shh signaling is critical for normal 
development.  Shh is a hybrid of two proteases, with a catalytically active carboxyl 
terminus and inactive amino terminus.  Activation of Shh requires autocatalytic 
activity of the carboxyl terminal portion of the protein, which is similar to family C46 
cysteine proteases.  The amino terminal portion of the protein is then esterified and 
palmitoylated.  Both lipid modifications are necessary for normal signaling [143].  




fact coordinates a zinc ion and has conserved catalytic residues.  However, the active 
site is not required for signaling, as mutation of both the active site histidine and 
glutamic acid do not result in loss-of-signaling function.  Rather, conserved surface 
residues outside and partly on the edge of the pseudo-active site groove lead to 
reduced binding to Shh receptor Ptc1 and diminished hedgehog signaling [144].  
Unlike serine proteases that act as ligands through proteolytic activity, Shh acts as a 
ligand strictly through receptor binding.                       
 
Parasitic proteases 
 Proteases have been studied in parasites, from single cell pathogens to 
multicellular helminthic worms, for a variety of reasons.  They are essential for 
parasite host invasion through tissue digestion and penetration, nutrient acquisition, 
and evasion of host immune responses.  They make attractive drug targets as most 
families have described inhibitors.  In worms, many are glycosylated and expressed in 
the intestine, making them possible targets for antibody therapy.       
 Blood-feeding parasites rely on hemoglobin as a source of nutrition, not only 
for amino acids, but likely heme as well.  Like C. elegans, helminthic worms are 
heme auxotrophs, and therefore rely on host heme for survival.  In the hookworm 
Ancylostoma caninum, an ordered proteolytic cascade involving a cathepsin D-like 
aspartic protease (ARP-1), a cathepsin B-like cysteine protease (CP-2), and a 
metalloprotease (MEP-1) is involved in hemoglobin digestion and utilization.  
Although the ARP-1 and CP-2 can cleave native hemoglobin, MEP-1 requires initial 




hookworm Necator americanus can cleave native hemoglobin, whereas CP-2 requires 
initial cleavage by ARP-1 [146].  Interestingly, ARP-1 contributes to host specificity 
in hookworms, as ARP-1 from A. caninum cannot cleave human hemoglobin while N. 
americanus ARP-1 cannot cleave canine hemoglobin.  Furthermore, inactivation of a 
single class of enzymes in these parasites prevents growth using hemoglobin as a 
nutrient source, suggesting an ordered, rather than parallel cleavage with an aspartic 
protease being the initiator of the cascade.  Similar cascades are used by the nematode 
Haemonchus contortus [147].  Plasmomidum have also been shown to utilize a 
cascade that is initialized by an aspartic protease preceding a cysteine protease, 
followed by a metalloprotease, and ending with an exopeptidase for digestion into 
amino acids [148].  Therefore, it is likely that an aspartic-cysteine-metalloprotease 
cascade is conserved across blood-feeding phyla.          
 Proteases play an important role in helminthic skin penetration and tissue 
invasion.  L3 infective larvae of A. caninum have been shown to secrete a 
metalloprotease which degrades gelatin, collagen, laminin, and fibronectin. Similarly, 
N. americanus larvae in the infectious stage secrete metalloproteases that degrade 
collagen and elastin.  However, since pepstatin also inhibited invasion, an aspartic 
protease must also be involved [149].  In the trematode Schistosoma mansoni, the 
infective cercarial larvae utilize a serine protease similar to elastase for skin 
penetration and tissue invasion [150].  Furthermore, this protease may also play a role 
in host immune evasion as it can cleave human complement proteins and IgE [151].  
The trematode Fasciola hepatica is a food borne pathogen that penetrates the 




mature into adults.  At 21 days of age when the worms are penetrating host tissue, 
they specifically upregulate cathepsin L-like cysteine proteases.  Accordingly, it was 
shown that cysteine protease activity was important for gut penetration [152, 153].   
Like helminths, the kinetoplastid parasites Leishmania and Trypanosoma 
utilize proteases for host invasion.  During the promastigote stage in the gut of the 
sandfly, a metalloprotease called GP63 (family M8) on the Leishmania cell surface 
accounts for 1% of total promastigote protein.  GP63 has been implicated in host 
immune evasion, phagocytosis into macrophages, and survival of the intracellular 
amastigotes within macrophages [154].   Leishmania also express several cysteine 
proteases, primarily in amastigotes.  A cathepsin L-like cysteine protease, CPB, was 
shown to be important for infection and virulence in mice [155].  Serine proteases 
have also been implicated in Leishmania survival and virulence [156, 157].  
Similarly, metalloprotease, serine protease, and cysteine protease activity have been 
shown to be important for  Trypanosoma cruzi virulence, with the latter also 
important for T. brucei virulence [154, 158, 159]. 
 Clearly proteases play an essential role in parasite metabolism and host 
invasion.  However, the mechanisms and the full extent to which they are required 
have yet to be elucidated.  In addition to degradation of host tissue for invasion and 
nutrients, parasite proteases can alter host signaling for their own benefit.  An 
interesting interaction occurs between the parasitoid wasp Cotesia congregata and its 
hornworm host Manduca sexta.  The wasp coinjects the symbiotic virus, C. 
congregata Bracovirus, long with fertilized eggs into the host.  The virus is essential 




host tissue, which inhibits host cysteine proteases [160].  However, it is not known 
how these host proteases defend against parasitism.   Understanding these basic 
biological interactions between host and parasite will be important for the 
development of effective drugs that target parasite proteases.   
 
Problem Statement   
Heme is required as a prosthetic group in proteins by most living organisms.  
Although heme levels can be regulated within each cell by heme synthesis and 
degradation, evidence exists that heme can also be transported in toto between cells.  
However, the pathways for the directed movement of heme between cells remain poorly 
defined due to interference from heme synthesis.  To uncover these pathways, we have 
taken advantage of the nematode C. elegans, which is a heme auxotroph and thus relies 
on dietary heme to fulfill its heme requirements.  To maintain a balance between heme 
uptake, availability, and storage we hypothesize that bidirectional signaling must exist 
between the intestine and extraintestinal tissues to control systemic heme homeostasis.  
We show that the protease homologs, HRG-7 and HRG-8, are secreted from the intestine 
and localize to neurons.  Depletion of either gene results in an intestinal heme deficiency 
signal, suggesting a neuron to intestine feedback.  The neurons regulate systemic heme 
levels by signaling to the intestine through the bone morphogenic protein homolog, DBL-
1.  Remarkably, depletion of HRG-7 and DBL-1 simultaneously results in an enhanced 
heme deficiency signal and growth phenotype, indicating that the neuron-gut axis is 







Chapter 2: Materials and Methods 
 
C. elegans culture 
Worms were maintained in axenic liquid mCeHR2 medium supplemented with 20 
µM heme with continuous shaking or on nematode growth medium (NGM) plates 
seeded with OP50 bacteria at 15°C.  NGM plates contained 3 g/L NaCl, 2.5 g/L 
peptone, 20 g/L agar, 5 mg/L cholesterol, 0.1 M CaCl2, 0.1 M MgSO4, and 25 mM 
KH2PO4. [161-163] 
 
Synchronization of C. elegans  
Worms were collected from plates with M9 buffer (86 mM NaCl, 42 mM Na2HPO4, 
22 mM KH2PO4, and 1 mM MgSO4), washed three times to remove bacteria, then 
resuspended in 0.1 M NaCl. Worms from liquid mCeHR-2 medium were harvested 
by centrifugation at 800 x g for 5 minutes, and then resuspended in 0.1 M NaCl.  
Gravid worms were allowed to settle on ice for 5 minutes. The supernatant was 
aspirated and remaining worms were bleached using a 1.1% sodium hypochlorite and 
0.55 M NaOH solution. After 5 minutes, embryos were released from adult worms 
and the mixture was centrifuged (800 x g, 1 minute) and washed twice with sterile 
water. Embryos were suspended in M9 buffer and allowed to hatch overnight.   
 
Worm strains 
Worms strains used in this study are listed in Appendix I.  N2, BW1496, RW10745, 




VC1478 was a kind gift from Dr. Yun Zhang at Harvard University.  Strains IQ6011, 
IQ8031, and IQ8333 were previously generated in the lab.  All other strains were 
generated in this study. 
 
Restriction enzyme cloning 
The Phrg-7::GFP and Phrg-8::GFP transcriptional fusion constructs were generated by 
restriction enzyme cloning into Fire vector pPD95.67.  For hrg-7, 0.7 kb of the 5’ 
flanking region was digested with HindIII and BamHI, and then ligated into the 
multiple cloning sequence (MCS) of pPD95.67.  For hrg-8, 2 kb of the 5’ flanking 
region was digested with HindIII and XbaI and then ligated into the pPD95.67 MCS.    
 
Gateway cloning 
All constructs apart from the hrg-7 and hrg-8 transcriptional reporters were generated 
using Multisite Gateway recombination (Invitrogen). Promoters, coding regions, and 
3’ untranslated regions were amplified with sequence-specific Gateway attB primers. 
PCR products were first recombined into donor plasmids, and then three donor 
plasmids were recombined into expression plasmids, according to the manufacturer’s 
instructions (Invitrogen). 
 
Generation of transgenic worms  
Reporter constructs mixed in a 2:1 ratio with the unc-119 rescue construct (18 µg 




bombardment using the PDS-1000 particle delivery system (Bio-Rad).  Transgenic 
lines were isolated after two weeks. 
 
Single worm PCR  
For single worm PCR, worms were lysed in lysis buffer (50 mM KCl, 10 mM Tris-
HCl, 2.5 mM MgCl2, 0.45% NP-40, 0.45% Tween-20, 0.01% gelatin, 1 mg/ml 
proteinase K) by incubation for 2 hours at -80°C, 1 hour at 65°C, and 30 min at 95°C. 
Worm lysates were added to PCR reactions with primers to detect wild-type and 
mutant alleles. Genotyping primers for dbl-1(nk3) and lin-15b(nk3) are listed in 
Appendix II.  For lin-15b genotyping, PCR product was purified with the Nucleospin 
PCR cleanup kit (Macherey-Nagel) and digested overnight with restriction enzyme 
BccI.  PCR product amplified from lin-15b(n744) mutation yielded fragments of 200 
and 300 bp after digestion.  PCR product from wild type lin-15b remained as a single 
band of 500 bp.   
 
RNA Interference by feeding 
RNAi experiments were performed by feeding worms the RNase III-deficient bacteria 
HT115(DE3) expressing double-stranded RNA (dsRNA) complimentary to the gene 
of interest.  dsRNA expression was induced by seeding bacteria on NGM plates 
containing 2 mM isopropyl-β-D-thioglactopyranoside (IPTG), 50 μg/mL 
carbenicillin, and 12 μg/mL tetracycline.  For the genome-wide RNAi screen, 
bacterial cultures of clones from the Ahringer and Vidal RNAi libraries were grown 




µM or 25 µM heme before seeding onto 12 well RNAi plates [164, 165].  Plates were 
left at room temperature overnight for dsRNA induction.  Forty L1 larvae from strain 
IQ6011 which had been grown in liquid media supplemented with 10 µM heme for 
five days were added to each well of the 12-well plates.  Each 12-well plate had 10 
wells seeded with experimental clones and one well seeded with each of the control 
clones, vector and hrg-4. The plates were incubated at 15°C overnight then moved to 
20°C for three additional days. The GFP levels in gravid adults were observed 
visually using a Leica Microsystems MZ16FA stereoscope. The intensity and pattern 
of GFP in gravid worms feeding on bacteria producing dsRNA against each library 
clone was compared to the intensity and pattern of GFP in same-stage worms feeding 





transgenes, RNAi clones were grown with 10 µM heme.  All clones 
were taken from the RNAi libraries except for hrg-7
300bp
, which was generated by 
ligating the first 300bp of hrg-7 into the L4440 plasmid (Fire Vector Kit, Addgene) 
and transforming into HT115(DE3) bacteria.     
 
RNA Interference by injection 
dsRNA was prepared using the Megascript T7 transcription kit (Ambion) according 
the manufactures instructions.  dsRNA was amplified from hrg-7 ORF and from the 
MCS sequence of pL4440 as a control.  dsRNA was injected at a concentration of 200 
ng /µl into strain IQ6916 P0 adults.  After injections, P0 adults were placed on RP523 
seeded NGM agar plates with 1µM or 50 µM heme and allowed to lay F1 progeny for 





Quantification of size and fluorescence using COPAS BioSort  
Fluorescence of transgenic C. elegans and analyses of growth rate was quantified 
using COPAS BioSort (Union Biometrica).  Worms were grown from L1 larvae to 
early adult or gravid stage on RNAi plates.  For evaluation of fluorescence, three 
parameters were measured: time of flight (length), extinction (optical density) and 
GFP intensity.  The settings for measuring GFP intensity in IQ6011 (Phrg-1::GFP) 
were gain = 2.5 and PMT voltage = 400 and in IQ8031 (Phrg-3::GFP) were gain = 2.5 
and PMT voltage = 600.  GFP was normalized to time of flight. 
 
Quantification of GFP expression in neurons 
After RNA interference (described above) in strain VC1478, adult worms were 
immobilized in 10 mm levamisole on a 2% agarose pad, and fluorescence microscopy 
images were quantified by Simple PCI  software (Hamamatsu) using the region of 
interest (ROI) method. GFP was quantified in 20 worms for each treatment. 
 
Embryonic lethality assay 
Strain VH624 was synchronized and placed on RNAi plates with bacterial cultures 
grown in 1/4 Luria-Bertani broth (LB) (2.5% tryptone, 1.25% yeast extract, and 10% 
NaCl weight by volume, 50 μg/mL carbenicillin, 12 μg/mL tetracycline) with no 
added heme or 50 µM added heme.  After 72 hours, adult worms were picked to fresh 
plates and allowed to lay embryos for 8 hours.  Hatched and unhatched worms were 





Growth on RP523 bacteria 
The heme-deficient E. coli strain RP523 was grown overnight in LB supplemented 
with 4 µM heme [166].  The following day, cultures were placed in fresh LB with 1 
µM or 50 µM heme and grown for 5.5 hours to an OD600 of 0.2.  Cultures were 
seeded on NGM agar plates overnight.  The following day, synchronized IQ6011 and 
IQ6311 L1 larvae were placed on the RP523 seeded plates and incubated at 20°C.  
Worms grown on 50 µM heme were quantified using COPAS BioSort after 72 hours.  





For detection of HRG-7, HRG-7-3xFLAG, and HRG-8-3xFLAG, between 2,500 and 
5,000 gravid or young adult worms were lysed in phosphate-buffered saline (PBS) 
with protease inhibitors (1 mM phenylmethylsulfonyl fluoride, 4 mM benzamidine, 2 
μg/ml leupeptin, and 1 μg/ml pepstatin), Lysing Matrix C beads (MP Biomedicals) in 
a FastPrep-24 Beadbeater (MP Biomedicals). Worm lysates were centrifuged 3 times 
at 10,000 x g for 10 minutes, then total protein concentration in the supernatants was 
measured using the Pierce BCA assay kit (Thermo Scientific).  Unboiled samples 
were mixed with Laemmli sample buffer and 50 μg protein / lane were separated on a 
10% SDS-PAGE gel and transferred to a nitrocellulose membrane. The membrane 




monoclonal antibody (Sigma) at a concentration of 1:1000.  Goat anti-rabbit HRP-
conjugated secondary was used for anti- HRG-7, or rabbit anti-mouse HRP-
conjugated secondary for anti-FLAG, at a 1:10,000 dilution, and blots were 
developed in SuperWest Pico Chemiluminescent Substrate (Thermo Scientific).  Bio-
Rad Image Lab software was used to quantify blots.    
 
DiI, FITC pulse 
To stain amphid and phasmid neurons, worms were removed from plates with M9, 
washed twice with M9, and resuspended in 100 µl M9.  A stock solution of 2 mg/ml 
5-fluorescein isothiocyanate (FITC) or 1,1'-dioctadecyl-3,3,3',3'-
tetramethylindocarbocyanine perchlorate (DiI) in dimethyl formamide (DMSO) was 
diluted 1: 200 into the mixture.  The tubes were wrapped in aluminum foil to avoid 
light exposure and incubated for 3 hours at room temperature.  The worms were 
washed three times with M9 to remove excess dye, then immobilized in 10 mM 
levamisole on a 2% agarose pad and imaged by fluorescence microscopy.  
 
Heme response assay 
For heme response assays, eggs were obtained from worm strains maintained in 
mCeHR-2 medium with 20 µM heme.  The following day, synchronized L1 larvae 
were placed mCeHR-2 medium with varying heme concentrations.  After 72 hours, 
GFP or mCherry fluorescence was quantified with the COPAS BioSort and analyzed 





HRG-7 and HRG-8 recoding 
To generate hrg-7 and hrg-8 RNAi resistant transgenes, the endogenous sequences 
were recoded by base pair substitution at degenerate sites and artificial introns were 
added using the C. elegans codon adapter [167].  Simultaneously, the endogenous 
sequences were recoded with the Genscript rare codon usage tool 
(http://www.genscript.com/cgi-bin/tools/rare_codon_analysis).  The two recoded 
sequences were combined to ensure the least amount of overlap with the endogenous 
sequences.  Finally, any contiguous stretches of six identical nucleotides between the 
recoded and endogenous sequences were changed manually, where applicable, to 
ensure RNAi resistance.  The sequences were then sent to Genscript (Piscataway, NJ) 
for synthesis.   The final recoded sequences are in appendix V.  Only the first 300 bp 
is recoded in RNAi resistant hrg-7 (hrg-7
PR







The genome-wide RNAi screen was performed with a Leica MZ16 FA 
stereomicroscope.  Fluorescent and DIC images were captured  using a Leica 
DMIRE2 epifluorescence microscope connected to a Retiga 1300 cooled mono 12-bit 
camera or a Zeiss LSM710 laser scanning confocal microscope. 
 
Worm lysate acid titration 
To evaluate HRG-7 processing, IQ7370 (Pvha-6::HRG-7::3xFLAG) were lysed in PBS 
+ 1% n-Dodecyl β-D-maltoside (DDM).  The pH of each sample was lowered with 




The pH was brought to 8 with 0.1 M NaOH before running samples on a sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel.    
 
RNAi of trafficking genes 
Synchronized N2 or IQ7670 L1 larvae were placed in mCeHR2 media supplemented 
with 10 µM heme for 30 hours.  Worms were then washed with M9 and transferred to 
RNAi plates.  Worms were harvested for immunoblotting or fluorescent imaging 48 
hours after transfer to RNAi plates.   
 
MuDPIT 
250,000 L1 larvae were placed in a 30 mL flask of liquid mCeHR2 medium 
supplemented with 4 µM and allowed to grow for 96 hours.  Worms were then 
harvested, washed with PBS three times, and resuspended with 500 µl FLAG buffer 
(100 mM Tris-HCl 8.0,150 mM NaCl, 5 mM Ethylenediaminetetraacetic acid 
(EDTA), 5% glycerol, 0.1% NP-40).  Worms were lysed using Lysing Matrix C 
beads in a FastPrep-24 Beadbeater.  Worm lysates were centrifuged 3 times at 10,000 
x g in 4°C for 10 minutes, then total protein concentration in the supernatants was 
measured using the Pierce BCA assay kit.  3-5 µg total protein in 500 FLAG buffer 
was mixed with 60 µl anti-FLAG affinity gel (M2 antibody, Sigma).  The mixture 
was rotated at 4 °C for 2 hours.  The anti-FLAG beads were then pelleted at 1000 g 
and washed three times with FLAG buffer and three times with FLAG buffer without 
NP40.  Protein was eluted off beads by eluting two times with 500 µl FLAG buffer 




were removed for western blot and silver stain, respectively.  Mass spectrophotometer 
analyses was performed at the University of California, Los Angeles. 
 
Bioinformatics  
Protein and DNA alignments were performed using ClustalW2  
(http://www.ebi.ac.uk/Tools/msa/clustalw2) [168].  Signal peptides were predicted 
with the SignalP 4.1 server (http://www.cbs.dtu.dk/services/SignalP) [169].  
Interaction networks were analyzed with geneMANIA (www.genemania.org).  




Statistical significance was determined using a Student’s t-test or one-way ANOVA 
in GraphPad Prism, version 5.00 (GraphPad Software, Inc.).  All data are presented as 















Chapter 3: A genome-wide RNAi screen reveals HRG-7 and HRG-8 as 
modulators of systemic heme homeostasis 
Summary 
Heme is an iron-containing tetrapyrrole that is required as a cofactor for 
proteins involved in diverse cellular functions [1, 2].  While heme synthesis and heme 
degradation have been extensively studied, other mechanisms of cellular and systemic 
homeostasis, such as transport, remain poorly understood.  We have previously 
shown that C. elegans does not synthesize heme, but must acquire it from the 
environment via the intestine by the paralogous permeases HRG-1 and HRG-4 [10, 
13].  Extraintestinal tissues in the worm including developing embryos, muscle, 
hypodermis, and neurons depend on heme exported by MRP-5 to fulfill their heme 
requirements.  Remarkably, depletion of mrp-5 results in upregulation of hrg-1 in the 
intestine, suggesting heme deficiency, despite the accumulation of heme in this tissue.  
Therefore, the heme deficiency signal emanating from the intestine is a consequence 
of heme deficiency in extraintestinal tissues, leading us to speculate that an intertissue 
communication network exists to regulate systemic heme homeostasis.  In order to 
uncover these interorgan signaling pathways we performed a genome-wide RNAi 
screen using the heme sensor strains IQ6011 (Phrg-1::GFP) and IQ8031 (Phrg-3::GFP), 
which express GFP from heme-responsive promoters in the intestine.  Roughly 30% 
of the identified genes for which expression data was available were not even 
expressed in the intestine, confirming that intestinal heme responsiveness was 
regulated by extraintestinal tissues.  Analyses of candidate genes with putative signal 




are regulators of heme homeostasis.  HRG-7 and HRG-8 are upregulated by low 
heme in the intestine, secreted from the basolateral surface of the intestine, and 
internalized by neurons.  Depletion of either gene results in upregulation of hrg-
1::GFP even though sufficient heme is present to repress GFP.  Together, our data 
suggest that communication between the intestine, the portal for heme entry, and the 
recipient tissue, the neuron, is essential for maintaining systemic heme homeostasis.  
 
Results 
A genome-wide RNAi screen identifies genes involved in heme homeostasis 
The lab has previously demonstrated that the heme sensor strain, IQ6011 
(Phrg-1::GFP), is a powerful tool for studying heme homeostasis [20].  In C. 
elegans, heme export from the intestine to extraintestinal tissues is mediated by the 
ABC transporter MRP-5 [12].  Depletion of mrp-5 results in upregulation of intestinal 
GFP in IQ6011 similar to that seen for the heme importer HRG-4, indicating heme 
deficiency (Figure 3.1A).  While this result is expected for hrg-4 knockdown, which 
prevents heme from entering the animal, it is surprising that mrp-5 knockdown results 
in a heme deficiency signal and intestinal heme accumulation [12].  However, 
because depletion of mrp-5 results in a failure to export heme from the intestine, 
extraintestinal tissues become heme deficient under these conditions.  We therefore 
reasoned that extraintestinal tissues must signal their heme deficiency status to the 
intestine, resulting in upregulation of HRG-1 to provide more heme to these tissues.  




































Figure 3.1: A genome-wide RNAi screen identifies genes involved in systemic 
heme homeostasis.    A) GFP fluorescence (120 worms per treatment) quantified 
from strain IQ6011 (Phrg-1::GFP) fed dsRNA against control vector, hrg-4, or mrp-5 
at 5, 25, 50, and 100 μM heme. GFP was quantified using COPAS BioSort. B) 













down ≈ 18,577 genes in IQ6011 by RNAi (Figure 3.1B).  Knockdown of 1,641 genes 
resulted in altered GFP expression compared to worms fed vector only, indicating 
alterations in heme homeostasis.  To rule out genes that regulate GFP expression non-
specifically, we rescreened the 1,641 modulators in worms expressing Pvha-6::GFP.  
These worms also express GFP specifically in the intestine but independent of heme 
concentrations.  Using this strain, we validated 1,017 genes as modulators of heme 
homeostasis.  GFP expression after RNAi knockdown of validated genes in IQ6011 
and another heme-sensor strain, IQ8031 (Phrg-3::GFP), was quantified using COPAS 
BioSort.  Like hrg-1, hrg-3 is transcriptionally upregulated in the intestine by low 
heme but through a different transcriptional pathway [11, 24].  Comparing the effect 
of RNAi knockdown in the two strains allowed us to differentiate between genes that 
had an overall effect on heme homeostasis and genes that were involved in a specific 
pathway.  Genes were considered candidates if knockdown resulted in upregulation of 
GFP in both strains by ≥ 1.5 fold or downregulation of GFP ≥ 2 fold (Figure 3.2A).   
In total, we found 187 genes that regulated GFP in both strains (Figure 3.2B).   
 
Systemic heme homeostasis is maintained by intertissue communication 
  Tissue specific expression patterns from reporter constructs or mRNA 
enrichment experiments were available for 94 out of the 187 genes that regulate GFP 
in IQ6011 and IQ8031 [171, 172].  Of these 94, approximately thirty percent were 
reported to be exclusively expressed in extraintestinal tissues, despite regulating 
intestinal GFP in both heme sensor strains (Figure 3.3A).  This supported our 

















Figure 3.2: GFP quantification of candidate genes in two heme sensor strains     
A) GFP fluorescence (80 worms per treatment) quantified from IQ6011 and IQ8031 
fed dsRNA against genes identified from a genome-wide screen for modulators of 
heme homeostasis.  Individual genes are plotted on the X axis by increasing GFP 
expression for both IQ6011 and IQ8031.  GFP is normalized to GFP expression in 
IQ6011 and IQ8031 fed dsRNA against vector only.  The red line indicates 1.5 fold 
increased GFP / vector GFP, the green line indicates 2 fold decreased GFP / vector 
GFP.  B) Venn diagram indicating the number of genes that upregulated GFP ≥ 1.5x 

























Figure 3.3: Systemic heme homeostasis is maintained by intertissue signaling.     
A) Pie chart indicating percentages of tissue-specific expression patterns of genes 
identified from our genome-wide screen.  Expression data was available for 94 out of 
187 genes. B)  Embryonic lethality in the RNAi hypersensitive strain VH624 (nre-1; 
lin-15b (hd126)) fed dsRNA against genes with putative signal peptides identified 
from the genome-wide RNAi screen.  P0 VH624 L1 larvae were fed dsRNA against 
indicated genes until gravid.  5 P0 worms were then picked to fresh RNAi plates and 
allowed to lay F1 progeny for 8 hrs.  Hatched and unhatched embryos were counted 
24 hours later. *P<0.05 compared to vector only in no added heme, n=3 (one-way 













homeostasis.  In order to uncover the mechanisms of heme-dependent signaling 
between tissues, we analyzed the 187 modulators for putative signal peptides using 
SignalP 4.1 (http://www.cbs.dtu.dk/services/SignalP) [169].  The presence of a signal 
peptide is an indication that a protein is translocated to the secretory pathway during 
translation and potentially secreted, thus capable of mobility and communication 
between tissues.  From the 187 ORFs, 10 had putative signal peptides and were 
expressed in a variety of tissues (Table 3.1).  In order to uncover which of these 
genes were crucial for heme homeostasis, we RNAi depleted each candidate gene in 
the RNAi hypersensitive strain VH624  (nre—1; lin15b (hd126)) and found that 
depletion of one candidate, C15C8.3, resulted in 90% embryonic lethality when 
worms were grown in low heme (Figure 3.3B).  Embryonic lethality was fully 
rescued by the addition of heme to RNAi bacteria cultures, indicating that this 
phenotype was reversible and dependent upon heme availability.  Together, our 
results indicate that C15C8.3 is required for heme homeostasis under heme limiting 
conditions.   
 
HRG-7 and HRG-8 are protease homologs  
   Microarray results, previously performed by our group, had indicated that 
C15C8.3 was upregulated by low heme, so we termed this gene heme responsive 
gene 7 (hrg-7) [20].   Blast searches against the predicted protein sequence of hrg-7 
revealed that it is a member of the A1 aspartic protease family, which includes the 































C12D12.1  Unknown Glycoprotein 





Basic proline-rich protein 
F19C7.1  Intestine  
F28B4.3  Unknown C-type lectin 
F32H5.1  Intestine Cysteine protease homolog 
F40F4.6  Unknown C-type lectin 
K03H1.5  Unknown Sushi domain containing protein 




proteases, HRG-7 is predicted to have a signal peptide, a propeptide which keeps 
these enzymes as zymogens until they encounter low pH, two conserved disulfide 
bonds, and two aspartic acid residues which are required for proteolytic activity 
(Figure 3.4A, B).  Antibody against endogenous HRG-7 confirmed it is synthesized 
as a pro-protein before maturation, as indicated by the appearance of a higher 
molecular weight band in addition to the expected molecular weight when worm 
lysates were immunoblotted for HRG-7 (Figure 3.4C).  RNAi knockdown of hrg-7 
reduces the intensity both bands, confirming the authenticity of the pro and mature 
forms of HRG-7.  Analyses of these candidates genes uncovered a second protease-
like gene, F32H5.1, which like hrg-7, upregulated GFP levels in IQ6011 when 
depleted, indicating heme deficiency.  Microarray results had showed that F32H5.1 is 
upregulated by low heme, so we termed this gene hrg-8.  The predicted HRG-8 
protein is homologous to the C1 cysteine proteases which include human proteases 
cathepsin B and cathepsin L (Figure 3.5A, B).  HRG-8 also has a signal peptide, a 
propeptide, and conserved disulfide bonds, but unlike HRG-7, lacks the catalytic diad 
of cysteine and histidine, which have been instead replaced by a methionine and 
alanine, respectively.  This suggests that HRG-8 may function as something other 
than a protease no longer requiring a functional active site.  Although attempts to 
obtain an antibody against endogenous HRG-8 were unsuccessful, we could detect 
transgenic HRG-8::3xFLAG with anti-FLAG antibody, suggesting that hrg-8 mRNA 






Figure 3.4: HRG-7 is an A1 protease homolog 
A) Conserved regions of aspartic proteases.  B) Homology model of HRG-7 using I-
TASSER.  The putative active site is indicated by a red circle.  The conserved 
disulfide bonds are indicated by green arrows. C) Immunoblot analysis of HRG-7 
expression in C. elegans. Membranes were probed with polyclonal anti-HRG-7 
antibody and then incubated with HRP-conjugated anti-rabbit secondary antibody.  
The HRG-7 antibody recognizes pro and mature HRG-7. * indicates pro-HRG-7.  + 


















































[S-S] cysteines for 
disulfide bonds 
D T G 
D S G  
D T/S G 
D T     A 
Consensus 
HRG-7 












Figure 3.5: HRG-8 is a C1 protease homolog 
A) Conserved regions of cysteine proteases.  B) Homology model of HRG-8 using I-
TASSER.  The canonical active site of C1 proteases, which is absent in HRG-8, site 
is indicated by a red circle. C) Immunoblot analysis of HRG-8-3xFLAG expression 
in IQ7380 (Pvha-6::HRG-8-3xFLAG::ICS::GFP).  Membranes were probed with 
monoclonal anti-FLAG antibody and then incubated with HRP-conjugated anti-



































































The heme-dependent regulation of hrg-7 and hrg-8 is specific to the intestine  
Previous studies have suggested that hrg-7 and hrg-8 expression is enriched in the 
intestine [172, 173], and expression is regulated by heme [20].  Therefore, we sought 
to address two questions: 1) are hrg-7 and hrg-8 expressed at all in extraintestinal 
tissues, and 2) is heme-dependent expression restricted to the intestine?  To answer 
these questions, we constructed hrg-7 and hrg-8 transcriptional reporters by fusing 
the 5’ flanking region of each gene upstream of GFP.  Interestingly, within the hrg-7 
5’ flanking sequence there was a highly conserved region about 200 bp upstream of 
the start codon which showed high similarity to the  HEme Responsive Element 
(HERE) previously characterized in the hrg-1 promoter (Figure 3.6A B) [24].  As in 
the hrg-1 promoter, the putative hrg-7 HERE was flanked by GATA sites, enhancer 
elements that bind the transcription factor ELT-2 and are responsible for intestinal 
expression in C. elegans [173].  Together, this analysis predicts that like hrg-1, hrg-7 
is upregulated by low heme specifically in the intestine.  This predicted pattern of 
regulation was confirmed by the Phrg-7::GFP transcriptional reporter strain IQ7701, 
which expressed strong GFP in the intestine when worms were grown in low heme 
(Figure 3.7A).  Worms expressing an hrg-7 transcriptional reporter in which the 
seven nucleotides on the 3’ end of the HERE were mutated (G→T, C→A, T → G, 
A→C) did not show GFP expression under low heme, indicating that the hrg-7 HERE 
is functional and mediates the heme-dependent expression of hrg-7 (Figure 3.7B).  
Finally, western blot analyses of HRG-7 expression showed that protein levels closely 




















Figure 3.6: The hrg-7 5’ flanking region has a conserved HERE and GATA sites 
A) ClustalW alignment of the hrg-7 5’ flanking region with homologous sequences in 
C. briggsae and C. remanei.  White text with black background indicates a conserved 
nucleotide in all three species.  Red box indicates HERE.  B) Alignment of the hrg-1 
transcriptional regulatory region with the putative hrg-7 transcriptional regulatory 
region.    Red box indicates HERE. White text with black background indicates 












Figure 3.7: hrg-7 is specifically upregulated in the intestine under low heme 
conditions 
A) GFP expression in strain IQ7701 (Phrg-7::GFP) grown in varying heme 
concentrations.  GFP was quantified with the COPAS BioSort. Graph represents 3 
replicates with 100 worms per replicate.  B)  GFP expression in IQ7701 and IQ7702 
(Phrg-7
mut
::GFP) in 4 µM heme.  GFP was only detectable in IQ7701. C) Immunoblot 
analysis of HRG-7 expression  in N2 grown in increasing heme concentrations. 
Membranes were probed with polyclonal anti-HRG-7 antibody and then incubated 
with HRP-conjugated anti-rabbit secondary antibody. * indicates pro-HRG-7.  + 
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heme-dependent transcriptional regulation plays a major role in HRG-7 protein levels 
(Figure 3.7C). 
 Although the 5’ flanking region of hrg-8 did not contain a HERE, there were 
two conserved GATA sites, supporting previous reports indicating that hrg-8 
expression was enriched in the intestine (Figure 3.8A).  As predicted, worms 
expressing Phrg-8::GFP (IQ7801) showed strong intestinal GFP expression (Figure 
3.8B).  In addition to the intestine, IQ7801 worms also expressed GFP in a single 
neuron pair in the head.  Although these neurons did not take up DiI, which labels the 
plasma membranes of amphid and phasmid sensory neurons, they were situated 
between neurons that did, suggesting that this neuron pair could be the AFD neurons 
(Figure 3.8C).  AFD neurons are also amphid sensory neurons but their dendrites are 
not exposed to the environment, preventing dye labeling.  To examine whether hrg-8 
was indeed expressed in AFD neurons, we crossed IQ7801 to worms expressing Pgcy-
8::mCherry, which is specifically expressed in the AFD neuron pair.  GFP and 
mCherry colocalized in crossed progeny, indicating that in addition to the intestine, 
hrg-8 is expressed in the AFD neuron pair (Figure 3.8D).  Next, to confirm 
microarray results indicating hrg-8 is heme-responsive, we grew IQ7801 in mCeHR-
2 media supplemented with 4, 20, 100, or 500 µM heme.  GFP expression was 
strongest at 4 µM heme but was still evident at 500 µM heme, indicating that 
although hrg-8 is heme-responsive, it is expressed over a broad range of heme 
concentrations (Figure 3.9A).  There were no heme-dependent changes in expression 
in the AFD neuron pair, indicating that the heme-dependent transcriptional regulation 




Figure 3.8:  hrg-8 is expressed in the intestine and AFD neuron pair 
A) ClustalW alignment of the hrg-8 5’ flanking region with homologous sequences in 
C. briggsae and C. remanei.  White text with black background indicates a conserved 
nucleotides in all three species.  Blue boxes indicate GATA elements. B) Intestinal 
GFP expression in strain IQ7801(Phrg-8::GFP).  C) Neuronal GFP expression in strain 
IQ7801(Phrg-8::GFP)  pulsed with 10 µg /ml DiI for 3 hrs. D) GFP and mCherry 
expression in double transgenic worms expressing Phrg-8::GFP and Pgcy-8::mCherry, 























































C. elegans   AACAATCTTCTTATCTTTTC-TTATCG---TTTCTGCTCTTTTCCCTCTC 
C. remained  AACAGTCTTCTTATCTTTTC-TTATCGCTCTTTCTGCTCTTTTCTTTCTC 












































Figure 3.9: hrg-8 expression is regulated by heme in the intestine but not in the 
AFD neuron pair 
GFP expression in strain IQ7801(Phrg-8::GFP) grown in 4, 20, 100, or 500 µM heme.  
Images are 63 X. A) GFP in the intestine, which is strongest at 4 µM heme. B) GFP 
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HRG-7 and HRG-8 are secreted from the intestine and localize to neurons 
 Having established that hrg-7 is exclusively expressed in low heme in the 
intestine and hrg-8 is expressed in the intestine and AFD neuron pair over a broad 
range of heme concentrations, we next sought to uncover the localization of HRG-7 
and HRG-8 by fusing their 5’ flanking regions and coding sequences in frame with 
mCherry (strain IQ7777 and IQ7888, respectively).  We expected three possible 
outcomes based on the localization of known A1 and C1 proteases in mammals and 
helminths: 1) lysosomal localization; 2) apical secretion into the gut lumen; 3) 
basolateral secretion into the pseudocoelom [147, 174-176].  For strain IQ7777 (Phrg-
7::HRG-7::mCherry), we observed weak mCherry fluorescence in the intestine but 
strong fluorescence in coelomocytes, macrophage like cells that take up substances 
non-specifically from the pseudocoelomic fluid and are used as a marker of secretion 
in C. elegans (Figure 3.10A) [177].  Therefore, the presence of HRG-7::mCherry in 
coelomocytes indicated that it was secreted from the basolateral membrane of the 
intestine into the body cavity.  This localization was not likely due to ectopic 
expression because we did not observe fluorescence in coelomocytes at 20 µM heme, 
and we have previously demonstrated that the HERE motif is only active in the 
intestine [24].  Additionally, we observed mCherry fluorescence in distinct punctae in 
the anterior and posterior of the worm, suggesting that HRG-7 is specifically targeted 
after secretion (Figure 3.10B). To analyze HRG-8 localization, we crossed the 
transgene Phrg-8::HRG-8::mCherry into IQ7801 to obtain the double transgenic strain 
IQ7880 (Phrg-8::GFP, Phrg-8::HRG-8::mCherry).  IQ7880 showed GFP and mCherry 




Figure 3.10: Secreted HRG-7::mCherry localizes to coelomocytes and punctae in 
the anterior and posterior of the worm 
mCherry expression in IQ7777 (Phrg-7::HRG-7::mCherry).  A) mCherry expression in 
coelomocytes.  Intestine is indicated by yellow lines, the coelomocytes are indicated 
by a white arrow.  Scale bar = 20 µm. B) mCherry expression in anterior and 















































































HRG-8 is also secreted from the basolateral membrane of the intestine (Figure 
3.11A).  HRG-8::mCherry was localized as punctae in the anterior of the worm, a 
portion of which was distinct from  the AFD neuron pair (Figure 3.11B).  To confirm 
that the observed localization patterns were not due to ectopic expression in 
extraintestinal tissue, we expressed HRG-7 and HRG-8 mCherry translational 
reporters from the intestine specific vha-6 promoter [178].  In strains IQ7670 (Pvha-
6::HRG-7::mCherry) and IQ7680 (Pvha-6::HRG-7::mCherry) we observed 
accumulation of mCherry in coelomocytes and distinct punctae in the anterior and 
posterior of the worm even though the protein was being specifically expressed from 
the intestine (Figure 3.12A, B). Next, we sought to clarify the specificity of this 
localization by analyzing two additional strains: IQ8333 (Pvha-6::HRG-3::mCherry) 
and IQ8630 (Pvha-6::HRG-3SP-mCherry).  HRG-3, like HRG-7 and HRG-8, is 
secreted from the basolateral membrane of the intestine but localizes to developing 
oocytes and embryos [11].  The second strain, IQ8630, expresses mCherry with the 
amino terminal signal peptide of HRG-3, allowing mCherry to go through the 
secretory pathway.  Expectedly, both these strains showed strong mCherry 
fluorescence in coelomocytes although neither recapitulated the fluorescence 
localization pattern of HRG-7::mCherry and HRG-8::mCherry (Appendix IIIA, B).   
To determine the target tissue of HRG-7 and HRG-8, we crossed tissue 
specific GFP or YFP markers into IQ7670 and IQ7680.  The markers used included 
Pceh-22::GFP (pharyngeal muscle), Pdpy-7::YFP (hypodermis),  Pmyo-2::GFP (body wall 
muscle) and Punc-119-2::GFP (neurons).   For both HRG-7::mCherry and HRG-




Figure 3.11: Secreted HRG-8::mCherry localizes to coelomocytes and punctae in 
the anterior of the worm 
GFP and mCherry expression in IQ7880 (Phrg-8::GFP, Phrg-8::HRG-8::mCherry).  A) 
GFP and mCherry expression in the intestine and coelomocytes.  Only mCherry is 
detected in coelomocytes.  B) GFP and mCherry expression in the anterior of the 
worm.  mCherry is detected in tissue distinct from the AFD neuron pair, which is 
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Figure 3.12: Intestinally driven HRG-7 and HRG-8 localize to coelomocytes and 
punctae in the anterior and posterior of the worm 
A) mCherry expression in the coelomocytes, anterior and posterior of strain IQ7670 
(Pvha-6:HRG-7:mCherry)  B) mCherry expression in the intestine and coelomocytes, 
anterior and posterior of strain IQ7680 (Pvha-6:HRG-8::mCherry).  White arrows 



















(Figure 3.13A, Appendix IV).  Confocal microscopy at higher magnifications 
revealed that HRG-7::mCherry and HRG-8::mCherry localized to neurons and that 
these proteins may be internalized (Figure 3.13B).  Both fusion proteins appeared to 
localize to a subset of neurons, with the strongest signal near the nerve ring.  Amphid 
sensory neurons, whose cell bodies are located posterior to the nerve ring, are 
involved in  nutrient homeostasis through signaling to the intestine to initiate lipolysis 
[74].  To determine if HRG-7 and HRG-8 localized to sensory neurons, we pulsed 
IQ7670 and  IQ7680  with fluorescein isothiocyanate  (FITC) for 3 hours.  Similar to 
DiI, amphid neurons take up FITC due to their direct contact with the external 
environment.  We observed HRG-7::mCherry and HRG-8::mCherry within the same 
neurons that took up FITC, suggesting that HRG-7 and HRG-8 localize, at least in 
part, to sensory neurons (Figure 3.14A, B).  Together, these data suggest that the 
upregulation of hrg-1::GFP due to depletion of hrg-7 and hrg-8 may be in response 
to a disruption in communication between the intestine and neurons to regulate 
intestinal heme transport during heme deficiency.    
 
Discussion 
The nematode C. elegans is unable to synthesize heme and is therefore reliant upon 
heme absorbed through the intestine to fulfill the heme requirement of all tissues.  We 






Figure 3.13 HRG-7::mCherry and HRG-8::mCherry colocalize with GFP 
expressed in neurons 
Expression of the pan-neuronal GFP marker Punc-119::GFP  crossed into strains 
IQ7670 (Pvha-6::HRG-7::mCherry) and IQ7680 (Pvha-6::HRG-8::mCherry).  A) 63X 
images, scale bar = 20µm.  B) 100X images, scale bar =  10 µM.  Yellow outline 
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Figure 3.14:  HRG-7::mCherry and HRG-8::mCherry localize to sensory 
neurons 
IQ7670(Pvha-6::HRG-7::mCherry) and IQ7680 (Pvha-6::HRG-8::mCherry) were pulsed 
with 10 µg /ml FITC for 3 h, then analyzed by confocal microscopy.  A) 
Representative image of anterior of IQ7670 adult. B) Representative image of 
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HRG-1 and HRG-4, while the ABC transporter MRP-5 exports heme from the 
basolateral membrane of the intestine into the pseudocoelom to be utilized by 
extraintestinal tissues [12, 13].  Surprisingly, depletion of mrp-5 results in 
upregulation of GFP in the heme sensor strain IQ6011 despite resulting in intestinal 
heme accumulation.  This suggests that the heme deficiency signal observed in the 
absence of MRP-5 is likely originating from extraintestinal tissues.  Data from our 
genome-wide RNAi screen for modulators of heme homeostasis supported the 
existence of an intertissue communication network, as ~30% of the genes identified 
from the screen were not reported as being expressed in the intestine, despite 
regulating two intestinal heme reporters.  Analyses of candidate genes with signal 
peptides uncovered the aspartic protease-like HRG-7 and the cysteine protease-like 
HRG-8 as potential secreted regulators of heme homeostasis.  Further analyses 
revealed that HRG-7 and HRG-8 are upregulated by low heme in the intestine, are 
then secreted and, surprisingly, localize to neurons.  Therefore, the communication 
between the intestine and extraintestinal tissues is likely bidirectional, and the 
communication between the gut and neurons may be of particular importance. 
It is intuitive that extraintestinal signals, which rely on the intestine for heme, 
can direct the intestinal release of heme, but why does a signal also need to come 
from the intestine, the source of heme?  In vertebrates, several nutrient receptors that 
are expressed on the tongue are also expressed in the intestinal EECs, including the 
sugar receptors T1R2 /T1R3 [179].  When these receptors are activated by sugars, the 
EECs secrete GLP-1 and GIP that target the brain and pancreas, resulting in altered 




content is communicated to other tissues through BMP6 [180].  By probing the 
environment and its own nutrient content, the intestine is able to signal nutrient 
availability to extraintestinal tissues, allowing them to adapt accordingly.  In this 
fashion, intestinal sensing and signaling through HRG-7 and HRG-8 may allow 
extraintestinal tissues to adapt to varying environmental heme availability. 
It is noteworthy that promoters of only three genes, hrg-1, mrp-5, and hrg-7, 
contain the cis HERE motif.  HRG-1 is involved in the release of heme stored in 
vesicles while MRP-5 allows heme to be exported from basolateral membrane of the 
intestine.  HRG-7, meanwhile, may facilitate heme utilization in extraintestinal 
tissues.   Therefore, each of the genes regulated by the HERE are interlinked; heme 
import, heme export, and integration of heme import and export with the rest of the 
body.  Furthermore, our data indicate that the intestinal HERE can receive signals 
from distal tissues, giving these tissues input into control of intestinal heme levels.  
Together, this implicates that the HERE has an important role beyond the intestine.           
Why do HRG-7 and HRG-8 localize to amphid sensory neurons?  
Interestingly, sensory neurons in C. elegans are unique in that they are the only cell 
types that are ciliated.  Ciliated sensory neurons control systemic lipid homeostasis by 
regulating intestinal fat storage, which similarly to heme homeostasis likely requires 
bidirectional signaling between neurons and the intestine.  This regulation is 
dependent on a protein called TUB-1, which is most strongly expressed in amphid 
and phasmid neurons, which are poised for sensing external and internal nutrient 
levels [74].  Furthermore, intact cilia are required for normal lipid homeostasis, and 




neurons are uniquely adapted and have an emerging role in systemic nutrient 
homeostasis.  
Although it is anticipated that pathways exist that allow the intertissue 
distribution of heme in a heme auxotroph such as C. elegans, several lines of 
evidence suggest that heme is also transported between cells in organisms that make 
heme.  Disruptions to heme homeostasis or systemic iron homeostasis can result in 
anemia, so intertissue heme trafficking cannot substitute for heme synthesis.  
However, different tissue types have different heme requirements, and some tissues 
may rely more on heme uptake than others.  Additionally, intertissue heme transport 
may be relevant during iron deficiency or pathological states [17, 182].  Taken 
together, our results indicate that an intertissue signaling network exists for 
maintenance of systemic heme homeostasis in C. elegans, and based on evidence 
supporting intertissue heme distribution in vertebrates, portions of this network may 











Chapter 4: Characterization of HRG-7 and HRG-8  
Summary 
 Our genome-wide screen for modulators of systemic heme homeostasis 
revealed that the protease homologs HRG-7 and HRG-8 are secreted from the 
intestine and localize to neurons to mediate systemic heme homeostasis.  Here, we 
show that although both genes are required for normal growth and reproduction, only 
the hrg-7 growth defect can be rescued by heme supplementation.  Moreover, 
ectopically expressed HRG-7 and HRG-8 regulate heme homeostasis only when 
expressed from the intestine, but not from the neuron or muscle.  Intestinal secretion 
of HRG-7 is a prerequisite for proper function, as depletion of specific trafficking 
factors revealed that the secretion and maturation of HRG-7 require post-Golgi fusion 
events and low pH.  Unlike other protease orthologs, cleavage of the HRG-7 
propeptide requires a trans-acting protease and mutating the active site did not 
eliminate rescue of hrg-1::GFP upregulation in the intestine.  These results reveal 
that, at least, a portion of the regulatory function of HRG-7 is independent of its 
proteolytic activity.  Together, our data indicate that HRG-7 and HRG-8 must be 
secreted from the intestine to regulate hrg-1::GFP, and this regulation may be 
independent of proteolytic activity.  Although proteases have been implicated in the 
breakdown of hemoglobin and therefore heme uptake in helminthic worms, the use of 
protease-like molecules to govern systemic homeostasis of a specific micronutrient is 






HRG-7 and HRG-8 are required for normal growth and reproduction 
  As previously mentioned, depletion of hrg-7 in the RNAi hypersensitive 
strain VH624 results in embryonic lethality, which can be rescued by heme 
supplementation of bacterial RNAi cultures.  This phenotype suggested that hrg-7 
was required for normal growth specifically in heme-limiting conditions.  To further 
evaluate the correlation of hrg-7 with organismal heme levels, we knocked down hrg-
7 by dsRNA injection in strain IQ6916, a double mutant for hrg-1 and hrg-4.  IQ6916 
worms show a heme-dependent growth delay due to reduced intestinal heme import 
[19].  The  F1 progeny from P0 worms injected with dsRNA were grown on heme 
synthesis deficient RP523 bacteria supplemented with 1 µM or 50 µM heme [166].    
While worms injected with dsRNA against control vector at 1 µM heme showed 
minimal growth delay compared to worms grown at 50 µM heme, worms injected 
with dsRNA against hrg-7 at 1 µM heme were severely growth retarded (Figure 
4.1A).  This phenotype was fully rescued by supplementation with 50 µM heme, 
confirming that hrg-7 is required specifically when organismal heme levels are low.   
Depletion of hrg-8 in strain VH624 did not result in embryonic lethality.  
However, hrg-8 depleted worms had a slight growth delay and appeared to produce 
less F1 progeny than worms fed dsRNA against vector control only.  Therefore, we 
performed a brood size experiment to evaluate the effects of hrg-8 on reproduction.  
Synchronized VH624 L1s were fed dsRNA against control vector or hrg-8 for 72 





Figure 4.1:  HRG-7 and HRG-8 are required for normal growth and 
development 
A) Growth analyses of IQ6916 (hrg-1(tm3199), hrg-4(tm2994)) injected with dsRNA 
against control vector or hrg-7 and supplemented with 1 µM or 50 µM heme.  Images 
are 20x.  B) F1 brood size analyses of strain VH624 (nre-1; lin-15b(hd126)) fed 
dsRNA against control vector or hrg-8.  Graph is representative of 3 replicates, with 3 
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hrg-8 RNAi worms had a significantly reduced brood size (Figure 4.1B).  This 
reduction in brood size was independent of heme concentration.  Notably, an hrg-8  
deletion allele (ok2017) is homozygous embryonic lethal, and neither excess heme 
nor ectopic expression of hrg-8 rescued embryonic lethality. 
Together, our data indicate that HRG-7 is crucial under low heme conditions, 
while HRG-8 appears to be required normal growth and reproduction across a wide-
range of heme concentrations even though both genes are highly responsive under 
low heme.    
 
HRG-7 and HRG-8 need to be secreted from the intestine to suppress intestinal 
expression of hrg-1 
Our data had indicated that HRG-7 and HRG-8 are secreted from the intestine 
and localize to neurons.  However, it was unclear whether HRG-7 and HRG-8  A) 
had to be expressed specifically in the intestine; B) was functional only after 
secretion, and; C) whether internalization into its cognate tissue was essential for 
function.  In order to address these questions, we expressed HRG-7 and HRG-8 from 
various tissues or membrane anchored HRG-7 and HRG-8 to prevent its 
internalization into distal tissues (Figure 4.2A).  To test the functionality of these 
ectopically expressed transgenes we synthesized recoded hrg-7 (hrg-7
PR
) and recoded 
hrg-8 (hrg-8
REC
) by introducing silent mutations into the degenerate site of each 
codon (Appendix V).  These mutations result in the transgene being resistant to 
RNAi but not the endogenous hrg-7 and hrg-8.  Unlike hrg-8, recoding the entire 








 secretion and membrane 
anchoring by transgenic expression  
A) Model depicting HRG-7 and HRG-8 expressed transgenically in the intestine 
(endogenous tissue of origin), the muscle (ectopic expression) and neurons (target 
tissue), with and without tethering to the cell membrane.  B) Schematic for generation 
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 then generated a mCherry with or without a transmembrane domain on the carboxyl 
terminal.  We chose the transmembrane domain from the Tac antigen, which is the 
alpha chain of the interleukin-2 receptor,  or a GPI anchor .  We speculated that 







the cell surface with the protein facing the extracellular space, allowing contact 
with the pseudocoelom but preventing localization to distal tissues.  In addition to the 
mCherry tag, we generated constructs with an intercistronic (ICS) SL2 sequence 




to be translated 
independently from mCherry through a trans-splicing mechanism in the event that 
tagging the carboxyl terminus  interfered with function [183].  All the RNAi resistant 
transgenes were then driven from three different promoters: the intestine (vha-6), the 
body wall muscle (myo-3), or neuron (unc-119).  Finally, worms expressing each of 
these transgenes were crossed to IQ6011 to interrogate the consequences of these 
transgenes on intestinal hrg-1 expression (Figure 4.2B).   
For functional studies of HRG-7
PR





.  The former sequence only targets the first 300 bp of hrg-7, and 
thus does not knock down hrg-7
PR
, while the latter targets the entire hrg-7 ORF and 
will therefore knockdown both endogenous hrg-7 and hrg-7
PR
.  Indeed, western blots 
of non-transgenic worms and worms expressing Pvha-6::HRG-7
PR
::ICS::mCherry 
confirmed that our transgenes were functioning as expected (Figure 4.3A).  By 
comparing hrg-1::GFP expression in double transgenic worms after knockdown  of 




Figure 4.3: RNAi resistant HRG-7 driven from an intestinal promoter rescues 
Phrg-1::GFP expression 
A) Immunoblot analysis of HRG-7 and HRG-7
PR 
from  IQ6011 (Phrg-1::GFP) and 
IQ7711 (Pvha-6::HRG-7
PR





. Membranes were probed with polyclonal anti-HRG-
7 antibody and then incubated with HRP-conjugated anti-rabbit secondary antibody. * 
indicates pro-HRG-7.  + indicates mature HRG-7.  Arrowhead indicates tubulin  B) 
GFP fluorescence (120 worms per treatment) quantified from IQ6011 (Phrg-1::GFP) 
and IQ7711 (Pvha-6::HRG-7
PR





 at 10 µM heme. GFP was quantified using COPAS 
BioSort. ***P<0.001 (one-way ANOVA).  C) GFP fluorescence (120 worms per 
treatment) quantified from IQ6011 (Phrg-1::GFP) and IQ7771 (Pvha-6::HRG-
7
PR

















































function of the transgene, HRG-7
PR
.  We found that expressing untagged HRG-7
PR
 in 
the intestine, when endogenous hrg-7 is depleted with dshrg-7
300bp
, was sufficient to 
restore hrg-1::GFP levels to that observed in worms fed vector only (Figure 4.3B).  
This rescue is specific to hrg-7
PR





results in upregulation of hrg-1::GFP comparable to worms not expressing 
hrg-7
PR
.  Additionally, HRG-7
PR
 fused directly to mCherry showed significant rescue 
(P<0.001) (Figure 4.3C), indicating the HRG-7 with a carboxyl terminus tag still 
retains significant function and that the observed localization of HRG- 7::mCherry is 
authentic.  For HRG-8
REC
 with and without a mCherry tag, intestinal driven 
expression was sufficient to rescue hrg-1::GFP expression (Figure 4.4A, B).  




 secreted from an intestinal 
specific promoter is functional  in the IQ6011 strain.   
We postulated that if HRG-7 and HRG-8 are involved in cell non-autonomous 
communication, it was possible that they would retain function when expressed 
ectopically from another tissue, such as the muscle or directly in the target tissue – 
neurons.  However, we observed no rescue of hrg-1::GFP when endogenous hrg-7 
was depleted and HRG-7
PR
::ICS::mCherry was expressed from the muscle or neuron  
(Appendix VI A , neuron not shown).  To ascertain whether mature HRG-7
PR
 was 
even made in these tissues, we knocked down endogenous hrg-7 in strains ectopically 
expressing hrg-7
PR
 and immunoblotted for HRG-7.  We observed that mature HRG-7 
was only produced when expressed in the intestine (Appendix VI B).  The muscle 
expressed a higher molecular weight band that did not correlate with the mature 
HRG-7, and no HRG-7
PR















Figure 4.4: RNAi resistant HRG-8 driven from an intestinal promoter rescues 
Phrg-1::GFP expression 
A) GFP fluorescence (120 worms per treatment) quantified from IQ6011 (Phrg-
1::GFP) and IQ7811 (Pvha-6::HRG-8
REC
:ICS::mCherry, Phrg-1::GFP) fed dsRNA 
against vector or hrg-8 at 10 µM heme.  GFP was quantified using COPAS BioSort. 
***P<0.001 (one-way ANOVA).  B) GFP fluorescence (120 worms per treatment) 
quantified from IQ6011 (Phrg-1::GFP) and IQ7881 (Pvha-6::HRG-8
REC
::mCherry, Phrg-




 at  10 µM heme. GFP 








 was expressed from muscle or neuron (Appendix VI C, neuron not 
shown).  Together, these results indicate that HRG-7 and HRG-8 have to be 
synthesized in the intestine for function.    
 
HRG-7 secretion is required for function 
Next, we asked if HRG-7 and HRG-8 retained function when anchored to the 
intestinal plasma membrane facing the extracellular space, or if they required contact 





 to the plasma membrane proved unsuccessful.  Although placing the Tac 
receptor transmembrane domain on the carboxyl terminus of HRG-7
PR
::mCherry 
appeared to successfully membrane-anchor the chimeric protein, it was not localized 
to the plasma membrane.  Rather, it seemed to accumulate in large vesicles within the 
intestine, and not accessible to pseudocoelom as we could have expected (Appendix 
VII A).  Similar results were observed for HRG-8
REC
::mCherry-Tac.  A GPI anchor 
on the carboxyl terminus of HRG-8
REC
::mCherry did inhibit secretion, and we did not 




(Appendix VII B, HRG-7 not 
shown).  We also attempted to anchor HRG-8
REC
 using the LDLR receptor 
transmembrane domain.  However, similar to the Tac receptor, HRG-8
rec::
mCherry-
LDLR accumulated within intracellular vesicles in the intestine (Appendix VII C).  
Therefore, it remained inconclusive whether HRG-7 and HRG-8 required secretion 
and contact with distal tissues.       
Due to the technical difficulties we encountered trying to express chimeric 




efforts on deciphering the function of HRG-7 because of the heme-dependent 
phenotype of hrg-7 RNAi in worms.  During protein maturation, HRG-7 temporarily 
has an endogenous transmembrane domain; the signal peptide tethers HRG-7 to the 
ER prior to proteolysis by a signal peptidase.  Therefore, we mutated the signal 
peptidase cleavage site, A16-E17, to Y16-Y17 in HRG-7
PR
::mCherry.  A second 
possible cleavage site, Q20-F21, was also mutated to adjacent tyrosines.  These 
mutations result in the signal peptide remaining as a transmembrane domain, similar 
to a signal-anchor sequence. (TM-HRG-7
PR
::mCherry).  Unlike previous attempts to 
membrane anchor HRG-7
PR
, mutation of the signal peptide resulted in an even 
distribution of TM-HRG-7
PR
 throughout the intestine and prevented accumulation in 
extraintestinal tissues such as the coelomocytes, indicating that TM-HRG-7
PR
 was 
successfully membrane-anchored facing the luminal side of the secretory pathway 
(Figure 4.5A).  We then crossed Pvha-6:: TM-HRG-7
pr
::mCherry into IQ6011 (strain 
IQ7712) and evaluated hrg-1::GFP rescue when endogenous hrg-7 is knocked down.  
TM-HRG-7
PR
 had no effect on hrg-1 expression suggesting that HRG-7 must be 
secreted form the intestine to elicit a biological response (Figure 4.5B).  This result 
confirms that the heme deficiency signal observed in the intestine is through cell non-
autonomous mechanisms as HRG-7 accumulation within the intestine in the absence 








Figure 4.5: HRG-7 requires secretion from the intestine to function 





::mCherry.  Arrows indicate coelomocytes.  B) GFP fluorescence 
(120 worms per treatment) quantified from IQ6011 (Phrg-1::GFP), IQ7771 (Pvha-
6::HRG-7
PR
::mCherry, Phrg-1::GFP), and IQ7412 (Pvha-6::TM-HRG-
7
PR





at 10 µM heme. GFP was quantified using COPAS BioSort. ***P<0.001 (one-way 




























































HRG-7 secretion and maturation requires specific trafficking factors 
We found it intriguing that mature, functional HRG-7 could only be produced 
and secreted from the intestine, implying that there may be specific compartments or 
factors that aid in HRG-7 folding, maturation, and secretion.  To gain a better 
understanding of HRG-7 secretion, we drove HRG-7::mCherry expression from the 
hsp-16.2 promoter, which is active in several tissues including the intestine (IQ7170) 
[184].  Approximately 180 minutes after heat shock of IQ7170, mCherry fluorescence 
was clearly visible in the pseudocoelomic fluid (Figure 4.6A).  After 360 minutes, 
strong fluorescence was observed in coelomocytes without accumulation in the 
intestine, suggesting that HRG-7 is secreted shortly after translation (Figure 4.6B).  
To uncover regulators of HRG-7 secretion, we knocked down 45 known trafficking 
genes in strain IQ7670 [185].  We observed that depletion of the SNARE protein 
SNAP-29 or components of the vacuolar ATPase resulted in accumulation of HRG-
7::mCherry in the intestine (Figure 4.7A).  Moreover, depletion of these genes results 
in accumulation of pro-HRG-7 (Figure 4.7B).  Specific trafficking pathways are 
involved in the regulation of HRG-7 trafficking and maturation, as depletion of sec-6, 
a component of the exocyst complex, did not affect HRG-7.  Together, these results 
suggest that HRG-7 maturation and secretion requires specific factors involved in 
post-Golgi fusion events and vesicular acidification.  Additionally, we found that 
some of the factors that regulated HRG-7 did not regulate HRG-8 secretion and vice 
versa implying that even though there are commonalities to both proteins there are 
also differences in their membrane trafficking (Table 4.1).  It has been demonstrated 





















Figure 4.6: HRG-7 is quickly secreted from the intestine after translation 
A) mCherry expression in strain IQ7170 (Phsp-16.2::HRG-7::mCherry)  placed in 37°C 
for 30 minutes, then 20°C for 60, 180, and 360 minutes.  Arrowheads indicate 
pseudocoelom.  Images are 63x. Scale bar = 20 µm.  B) Quantification of 
coelomocytes using region of interest function on simple PCI software.                                                        
 
 
































Figure 4.7: HRG-7 secretion and maturation is regulated by specific membrane 
trafficking factors 
A) mCherry expression in strain IQ7670 (Pvha-6::HRG-7::mCherry) fed dsRNA 
against vector, snap-29, vha-1, and sec-6.  Images are 63x. Scale bar = 20 µm. B) 
Immunoblot analysis of strain N2  fed dsRNA against vector, snap-29, vha-1, and 
sec-6.  Membranes were probed with polyclonal anti-HRG-7 antibody and then 
incubated with HRP-conjugated anti-rabbit secondary antibody. * indicates pro-HRG-
7.  + indicates mature HRG-7.  Arrowhead indicates tubulin.   
 






















Table 4.1: Specific regulators of the secretory pathway direct HRG-7 and HRG-























Gene ID  HRG-7::mCherry  HRG-8::mCherry  Description 
 Intestine       Circulation  Intestine       Circulation  
Y113G7A.3 Increased      nc Increased       nc vesicle coat complex COPII, subunit SEC23 
F12F6.6 nc                  nc Increased       nc encodes one of two C. elegans Sec24 homologs 
K02D10.5 Increased      nc nc                   nc  SNAP-25 component of SNARE complex 
T14G10.5 Increased      nc Increased      nc gamma subunit of the coatomer (COPI) complex 
Y25C1A.5 Increased      nc Increased      nc beta subunit of the coatomer (COPI) complex 
ZK180.4 nc                  nc Increased      nc vesicle coat complex COPII, GTPase subunit SAR1 
T20G5.1 Increased      nc Increased      nc vesicle coat protein clathrin, heavy chain 
C01G8.5 Increased      Increased nc                  nc ortholog of the ERM family of cytoskeletal linkers 
R10E11.8 Increased      Increased nc                  Increased 16-kDa proteolipid of the vacuolar-type H+-ATPase 
R10E11.2 nc                  nc Increased      nc 16-kDa proteolipid of the vacuolar-type H+-ATPase 
T01H3.1 Increased      nc Increased      nc vacuolar H+-ATPase V0 sector, subunit c 
C17H12.14 Increased      nc Increased      nc E subunit of a V-ATPase (vacuolar H+-ATPase) 
ZK970.4 Increased      nc Increased      nc vacuolar H+-ATPase V1 sector, subunit F 
Y49A3A.2 Increased      nc Increased      nc vacuolar H+-ATPase V1 sector, subunit A 




regulator through proton transport [186].  Therefore, in order to further evaluate 
whether pH influenced HRG-7 maturation, we analyzed lysate from C. elegans 
expressing HRG-7::3xFLAG (strain IQ7370) at neutral or acidic pH.  Immunoblots of 
the 3xFLAG tagged HRG-7 show the presence of a discernible propeptide form of the 
protein indicative of a slower maturation time.  We capitalized on this aspect to study 
the dynamics of HRG-7 maturation.  While no HRG-7::3xFLAG propeptide 
processing occurs in lysates at pH 7.2, maturation is quickly induced in lysate titrated 
to pH 4, with over 90% of HRG-7-3xFLAG processed within 20 minutes (Figure 
4.8A).  We exposed IQ7370 lysate to a pH gradient to determine the optimal pH for 
processing and found that HRG-7::3xFLAG maturation  was expedited as acidity 
increased (Figure 4.8B).  These results confirm that HRG-7 requires trafficking 
through acidic compartments where it is processed to the mature form.  Because 
aspartic proteases such as pepsin undergo autocatalysis of the propeptide when 
exposed to acidic conditions, [187], while renin requires an unidentified trans-acting 
protease for maturation  [133], we interrogated whether HRG-7 requires the predicted 
D90 D318  active site aspartic acid residues maturation.  We mutated both D90 and 




(Figure 4.9A).  Mutation of the 
aspartic acid residues did not result in accumulation of pro-HRG-7, suggesting that a 
trans-acting protease must be responsible for pro-HRG-7 processing to the mature 
form (Figure 4.9B).  We next crossed Pvha-6::iHRG-7
PR
::ICS::mCherry into IQ6011 
(strain IQ7712) to evaluate whether the predicted catalytic residues were involved in 






















Figure 4.8: Acidic conditions facilitate HRG-7 maturation  
A) Immunoblot analysis of lysate prepared from strain IQ7370 (Pvha-6::HRG-
7::3xFLAG) at pH 7.2 and pH 4.  Membranes were probed with monoclonal anti-
FLAG antibody and then incubated with HRP-conjugated anti-mouse secondary 
antibody. * indicates pro-HRG-7-3xFLAG.  + indicates mature HRG-7-3xFLAG.  B) 
Quantification of immunoblot analyses of IQ7370 lysate and maintained at indicated 














7.26.5 6 5.5 5 4.5 4pH: 
Time = 20 min 
HRG-7-3xFLAG 
* 








Figure 4.9: HRG-7 does not require the predicted catalytic aspartates for 
maturation or regulation of hrg-1::GFP 
A) Cartoon depicting mutation of the predicted catalytic aspartic acid residues D90 
and D318 to alanines to make iHRG-7. B) Immunoblot analysis of lysate from N2, 
worms expressing Pvha-6::HRG-7::ICS::mCherry, and worms expressing Pvha-
6::iHRG-7::ICS::mCherry.  Membranes were probed with polyclonal anti-HRG-7 
antibody and then incubated with HRP-conjugated anti-rabbit secondary antibody. C) 
GFP fluorescence (120 worms per treatment) quantified from IQ6011 (Phrg-1::GFP), 
IQ7711 (Pvha-6::HRG-7
PR
:ICS::mCherry, Phrg-1::GFP), and IQ7712 (Pvha-6::iHRG-
7
PR





at 10 µM heme. GFP was quantified using COPAS BioSort. ***P<0.001 (one-way 
ANOVA). 












































D S G  D T A 





rescue of Phrg-1::GFP expression, indicating that HRG-7 function is, at least in part, 
independent of the predicted catalytic residues (Figure 4.9C).   
 
Discussion              
 We have demonstrated that functionally competent HRG-7 must be expressed 
from its native tissue of origin, the intestine, and secreted.  Further analyses of HRG-
7 through an RNAi screen of C. elegans trafficking factors reveal that maturation and 
secretion of HRG-7 requires acidification and post-Golgi fusion events.  The in silico 
prediction of putative active sites for HRG-7 is not essential for maturation, 
suggesting that either a trans-acting protease in the intestine is required for activation 
of HRG-7 or the presence of other active site residues.  Correspondingly, the 
predicted active site of HRG-7 was not required for hrg-1 regulation suggesting that 
systemic heme homeostasis may be independent of the canonical aspartic protease 
activity of HRG-7.    
Why do protease homologs, potentially devoid of catalytic activity, play such 
an important role in heme homeostasis?  Proteases have several features that make 
them attractive candidates for signaling mechanisms.  They are involved in 
interactions with their cognate substrates or inhibitors.  Many are secreted or localize 
to the secretory pathway, so they have signal peptides.  And, like many canonical 
signaling factors and hormones, they are inactive until removal of a propeptide, 
allowing a rapid cellular response to stimuli.  It is becoming evident that proteases 
have expansive and essential roles in intercellular cell signaling [126].  Furthermore, 




a canonical active site and may be pseudoproteases.  Currently the majority of 
pseudoproteases have no ascribed function, although several have been shown to be 
involved intercellular signaling [129].  Two secreted morphogens, HGF and sonic 
hedgehog, are proteolytically inactive pseudoproteases of the serine and 
metalloprotease families, respectively [143].  The Hedgehog morphogen has retained 
the predicted catalytic residues, H134 and D176, similar to those seen in the M15 
metalloprotease family, yet functions as a ligand through receptor binding rather than 
as a protease [142].  Moreover, active proteases can have signaling function 
independent of enzymatic activity.   Renin, a hormone which mainly functions in 
regulation of systemic blood pressure through processing of angiotensinogen, also has 
a receptor that can activate downstream signaling independent of the proteolytic 
active site [188].  Cathepsin D has been shown to act as a mitogen in tumor cells even 
after the active site is abolished [189].  It is possible that, as in the previous examples, 
HRG-7 and HRG-8 can continue to act as receptor ligands, independent of its 
inherent catalytic activity.  
    Both secreted HRG-7::mCherry and HRG-8::mCherry are functional only 
when secreted from the intestine.  It is likely that HRG-7 and HRG-8 are regulated by 
or interact with specific factors only expressed in the intestine for secretion, 
activation, and other processes.  HRG-7 secretion and maturation requires acidified 
compartments, the snare protein SNAP-29, and likely a trans-activating protease for 
propeptide removal.  VHA-1 of the v-ATPase complex involved in vesicular 
acidification has been reported as being enriched in the intestine, and SNAP-29 is not 




factors, whole compartments, such as the acidic “gut granules,” autofluorescent 
lysosome-like organelles, are specific to the intestine [191].  Therefore, as a 
specialized organ, the intestine may have unique properties and factors that allow 
expression of competent HRG-7 and HRG-8.   
Although HRG-7 and HRG-8 have several overlapping characteristics, HRG-
7 expression is completely repressed by 20 µM and growth phenotypes associated 
with hrg-7 depletion can be rescued by heme.  This suggests that HRG-7 is highly 
specific to heme homeostasis.  HRG-8, however, is expressed even at 500 µM heme 
and the growth and reproduction phenotype associated with HRG-8 depletion cannot 
be rescued by heme supplementation.  Therefore, either HRG-8 is required for heme 
homeostasis over a broad range of heme concentrations or has functions that are 
independent of heme homeostasis.  One possibility is that HRG-8 impacts several 
pathways and thus has several interactors, with each interactor conferring pathway 
specificity through receptor binding or some other mechanism.  Along those lines, 
endogenous HRG-8 is produced in both the intestine and neurons, yet HRG-8 only 
functions in heme homeostasis when expressed from the intestine.  This would 
suggest distinct functions for intestinal and neuronal HRG-8, possibly due to different 
interacting partners.  Our preliminary results show that HRG-7 and HRG-8 do not 
interact with each other as immunoprecipitations did not precipitate the corresponding 
interactor and they have different phenotypes when depleted in strain VH624.  
Alternatively, rather than directly binding interacting partners or a receptor, HRG-8 
may inhibit endogenous cysteine proteases.  In this case, RNAi depletion of HRG-8 




processes.  Biochemical analyses of HRG-8 is required to gain a better understanding 
of HRG-8 function. 
  
   






















Chapter 5: The neuron-gut axis is critical for systemic heme homeostasis 
 
Summary  
 Based on our results, we postulated that C. elegans maintains systemic heme 
homeostasis through bidirectional signaling between the intestine and extraintestinal 
tissues.  We have identified HRG-7 and HRG-8 as secreted proteins that are made in 
the intestine and localize to neurons.  HRG-7 in particular is crucial for C. elegans 
adaptation to low heme conditions.  The localization of HRG-7 and HRG-8 to 
neurons indicates that neurons may communicate back to the intestine.  However, our 
genome-wide RNAi would have missed identifying these signals, as C. elegans 
neurons are refractory to RNAi.  To circumvent this hurdle, we synthesized a 
neuronal RNAi-sensitive strain by crossing a lin-15b mutation into IQ6011 (IQ6015).   
Systematically knocking down 127 known morphogens and neuropeptides in C. 
elegans led to the identification of DBL-1 as an important mediator of neuron to 
intestine heme signaling.  Importantly, intestinal response to DBL-1 is dependent 
upon the transcription factor SMA-9, and disruption of this pathway results heme-
dependent growth impairment.  Depletion of both dbl-1 and hrg-7 results in a 
synthetic growth phenotype which is suppressed by environmental heme.  Together, 
these data implicate a bidirectional signaling system between the intestine and the 








Identification of the DBl-1 / SMA-9 signaling axis as a regulator of heme 
homeostasis 
 Our results suggest that neurons may play an important role in systemic heme 
homeostasis and intestinal heme uptake.  However, because neurons are refractory to 
RNAi in C. elegans, it is unlikely that neuronal signaling factors would have been 
depleted to result in a phenotype in our RNAi screen.  Therefore, we generated strain 
IQ6015, a neuronal RNAi hypersensitive strain, by introducing a lin-15b mutation 
(n744) into the IQ6011 heme sensor strain.  Mutations in lin-15b allow enhanced 
RNAi efficiency in neurons [192].   We then knocked down 127 genes (~83 percent) 
known to encode morphogens and neuropeptides in both IQ6011 and IQ6015.  We 
were interested in genes that, when depleted, caused an enhanced GFP phenotype 
specifically in IQ6015 as this would be indicative of gene knockdown in neurons.  
We uncovered four genes for which RNAi depletion resulted in significantly higher 
GFP expression in IQ6015 compared to IQ6011: the TGF beta-like dbl-1, the insulin-
like ins-21 and ins-32, and the neuropeptide-like nlp-12 (Figure 5.1A).  All four 
genes have been reported as being expressed in the nervous system [193-195].  Next, 
we cross-referenced the known physical and genetic interactors of each gene with 
candidates from our genome-wide screen to evaluate inter-tissue pathway 
connections.  Interestingly, we found a pathway connection between dbl-1 and sma-9, 
genes previously been shown to genetically interact to regulate body size (Figure 
5.1B) [196].   DBL-1 and SMA-9 are homologous to the human TGF beta 




Figure 5.1: The DBL-1 / SMA-9 signaling axis regulates hrg-1 expression 
A) GFP quantification of strain IQ6011 (Phrg-1::GFP) and strain IQ6015 (Phrg-
1::GFP; lin-15b(n744)) after knockdown of morphogens and neuropeptides.  Red 
data points are significant outliers in a regression curve as determined by SAS 
software.   120 worms were analyzed for each treatment.  GFP is fold change 
compared to worms fed control vector only B) geneMANIA genetic / physical 





















































































transcription factors, respectively.  No physical or genetic interactions were identified 
for ins-32 and nlp-12 (Appendix VIII).   
 To delineate the role of DBL-1 in heme homeostasis, we analyzed 
transcriptional reporter fusions for dbl-1and sma-9.  Interestingly, dbl::GFP was 
predominately expressed in neurons, while sma-9::HIS-24::mCherry was expressed 
in most somatic tissue, including the intestine (Figure 5.2A, B) [193, 196].  This 
indicates that the heme deficiency signal generated by depletion of DBL-1may be 
transmitted to the intestine through SMA-9.  In order to demonstrate that sma-9 was 
functioning in the same pathway as dbl-1 to regulate hrg-1, we knocked down sma-9 
in IQ6011 and the dbl-1 null mutant strain IQ6311 (dbl-1(nk3);Phrg-1::GFP;).  While 
knockdown of sma-9 results in significant increase of GFP in IQ6011 control worms, 
GFP levels were unaltered in dbl-1 (nk3) mutants, suggesting hrg-1 repression is 
dependent on dbl-1 via sma-9 (Figure 5.3A).  Interestingly, published microarray 
data indicate that ~10% of heme-responsive genes are also regulated by dbl-1, half of 
which have intestinal expression (Figure 5.3B, Table 5.1) [197].  Together, this data 
suggests that the DBL-1/ SMA-9 signaling axis has a strong influence on heme 
homeostasis, and in particular neuron to intestinal signaling. 
 
DBL-1 function is dose-dependent and is required for normal growth in low 
heme 
DBL-1 has been shown to affect body size in a dose-dependent manner [193]; 
dbl-1(nk3) mutants are small, while overexpression of GFP::DBL-1 results in long 


















Figure 5.2: Tissue specific expression of dbl-1and sma-9 
A) GFP expression in strain BW1946 (Pdbl-1::GFP).  Images are 63 x.  Arrowhead 
indicates head neurons.  Arrow indicates tail neurons.  * indicates body neuron.  B) 
mCherry expression in strain RW10745 (Psma-9::HIS-24::mCherry).  Images are 63 x.  










































Figure 5.3: DBL-1and SMA-9 coordinate to regulate neuron to intestine heme 
signaling 
A)  GFP fluorescence (120 worms per treatment) quantified from IQ6011 (Phrg-
1::GFP)  and IQ6311 (Phrg-1::GFP ; dbl-1(nk3)) fed dsRNA against vector or sma-9 at  
10 µM heme. GFP was quantified using COPAS BioSort. ***P<0.001 (t-test).  B) 
Venn diagram depicting overlap of heme-responsive genes and genes regulated by 






































expression Short Description 
B0218.8 clec-52 Yes 
 C03H5.1 clec-10 Yes 
 C04F6.1 vit-5 Yes vit-5 encodes a vitellogenin. 
C05C10.4 pho-11 
  C15C8.3 hrg-7 Yes 
 F09G2.3 pitr-5 
  F15E11.12 pud-4 Yes 
 F35C5.9 clec-66 Yes 
 F59D8.2 vit-4 Yes 
 H23N18.1 ugt-13 




   K01D12.14 hrg-2 
  K07H8.6 vit-6 Yes vit-6 encodes a vitellogenin precursor. 
K08E7.9 pgp-1 Yes 
pgp-1 is a member of the ABC transporter 
superfamily. 
K10C2.3 asp-14 
  M02D8.4 asns-2 Yes 
 M02H5.4 nhr-202 
  R02E12.6 hrg-1 Yes hrg-1 encodes a heme transporter. 
T05E12.6 
   T08A9.8 spp-4 Yes  
T24B8.5 
  




















homeostasis, we crossed overexpressed GFP:DBL-1 into IQ6211 to generate IQ6312 
(Phrg-1::GFP;Pdbl-1::GFP::DBL-1;  dbl-1(nk3)).  We grew each of the three strains, 
wild type dbl-1, dbl-1(nk3) null mutants, or  GFP::DBL-1 overexpressors over a 
range over of heme concentrations and evaluated intestinal hrg-1::GFP expression 
(Figure 5.4A, B).  Worms lacking dbl-1 phenocopied RNAi knockdown, leading to 
the upregulation of  hrg-1::GFP at all heme concentrations tested when compared to 
WT worms, confirming that DBL-1 is a repressor of hrg-1 (Figure 5.4C).  
Conversely, hrg-1::GFP expression was reduced in worms overexpressing 
GFP::DBL-1 compared to WT worms, confirming a dose-dependent effect of DBL-1.  
Together, these results indicate that neuronal 
expression of DBL-1 strongly influences intestinal hrg-1 expression.  Next, we grew 
IQ6011 and IQ6311 worms lacking dbl-1 on RP523 bacteria food supplemented with 
1 or 50 µM heme.  Worms lacking dbl-1 and grown on low heme were growth 
delayed, a phenotype suppressed by 50 µM heme (Figure 5.5).  This result suggested 
that DBL-1 is necessary for normal growth under low heme conditions.  Together, 
our data indicate that DBL-1 is an important regulator of heme homeostasis.    
 
DBL-1 and HRG-7 synergistically regulate heme homeostasis 
 We have shown that both HRG-7 and DBL-1 are secreted signals involved in 
long-range signaling to promote heme homeostasis.  Depletion of either dbl-1 or hrg-
7 result in overlapping heme-dependent phenotypes, despite being expressed in 
different tissues.  It is noteworthy that published microarray results show that hrg-7 




Figure 5.4: DBL-1 regulates hrg-1::GFP in a dose-dependent manner 
A) Schematic for genotyping dbl-1, dbl-1(nk3), and transgenic GFP::DBL-1.  Primer 
sequences are in appendix II.  B) Single worm PCR of IQ6011, IQ6311 (Phrg-1::GFP ; 
dbl-1(nk3)), and IQ6312 (Phrg-1::GFP Pdbl-1::GFP ; dbl-1(nk3)) worms with primers 
from panel A.  C) Fluorescence images and GFP quantification from IQ6011, 
IQ6311, and IQ6312  grown on 0P50 supplemented with indicated heme 
concentrations.  Images are 63x. Scale bar = 20 µm.  GFP fluorescence (100 worms 










































 dbl-1(nk3); GFP::DBL-1 
































Figure 5.5: DBL-1 is required for normal growth in low heme 
 Size analyses (200-300 worms per treatment) quantified from IQ6011 (Phrg-1::GFP)  
and IQ6311 (Phrg-1::GFP ; dbl-1(nk3))  fed RP523 E. coli grown in l µM or 50 µM 












DBL-1 is a regulator of hrg-1, and both hrg-1 and hrg-7 contain HERE motifs for 
heme-responsiveness.  To evaluate whether HRG-7 was also upregulated in the 
absence of dbl-1, we analyzed HRG-7 protein levels in strains IQ6011 (Phrg-1::GFP) 
and IQ6311 (Phrg-1::GFP; dbl-1(nk3)).  Unexpectedly, total HRG-7 was markedly 
decreased in worms lacking dbl-1.  Intriguingly, only the mature form was decreased, 
while the pro-form was slightly upregulated (Figure 5.6A).  This suggests that mature 
HRG-7 is not stable in the absence of DBL-1.  To evaluate whether the 
posttranslational regulation of HRG-7 by DBL-1 was dependent on sma-9, we 
analyzed HRG-7 expression in VH624 hypersensitive strain.  In contrast to dbl-
1mutants, RNAi of sma-9 resulted in increased mature HRG-7 (Figure 5.6B).  These 
results suggest that the DBL-1/SMA-9 pathway regulates hrg-7 at the transcriptional 
level, but DBL-1 may also have a sma-9 independent role in the post-translational 
regulation of HRG-7.         
To determine whether HRG-7 regulated DBL-1 expression, we knocked down 
hrg-7 in the DBL-1 translational reporter VC1478 (dbl-1(nk3); Pdbl-1::GFP::DBL-1).  
The depletion of hrg-7 did not result in any detectable changes in GFP::DBL-1 
expression (Figure 5.7A).  Our previous results had suggested HRG-7 preferentially 
localized to sensory neurons.  To evaluate whether these neurons also expressed dbl-
1, we generated the double transgenic strain IQ7671(Pvha-6::HRG-7::mCherry; Pdbl-
1::GFP).  GFP and mCherry were not present in the same neurons in this strain 
(Figure 5.7B).  Based on these experiments, we hypothesized that DBl-1 is a 
regulator of HRG-7 but HRG-7 is not a regulator of DBL-1 expression.  However, we 


















Figure 5.6: DBl-1 regulates HRG-7 levels post-translationally independent of 
SMA-9. 
A) Immunoblot analysis of HRG-7 expression in IQ6011 (Phrg-1::GFP)  and IQ6311 
(Phrg-1::GFP ; dbl-1(nk3)).  Membranes were probed with polyclonal anti-HRG-7 
antibody and then incubated with HRP-conjugated anti-rabbit secondary antibody. * 
indicates pro-HRG-7.  + indicates mature HRG-7.  Arrowhead indicates tubulin.  B) 
Immunoblot analysis of HRG-7 expression in VH624 fed  dsRNA against vector or 
sma-9. + indicates mature HRG-7.  Arrowhead indicates tubulin.  Blots were 
quantified with Chemidoc software.  N=5000 worms per treatment.  Images and 


































































Figure 5.7: HRG-7 does not regulate DBL-1 expression 
A) GFP fluorescence in neurons (20 worms each treatment) of  VC1478 (dbl-1(nk3); 
Pdbl-1::DBL-1GFP) fed ds RNA against control vector only or hrg-7.  Neurons were 
quantified using the Region of Interest function in simple PCI.  Graph is 
representative of two experiments. B) GFP and mCherry expression in strain 









To evaluate whether DBL-1 and HRG-7 regulated hrg-1 through the same 
pathway or independently of one another, we knocked down dbl-1, sma-9, and hrg-7 
either singly or together in IQ6015.  As expected, RNAi of  dbl-1 and sma-9 
simultaneously did not result in any further upregulation of GFP (Figure 5.8A).  
However, knockdown of dbl-1 and hrg-7 simultaneously lead to significantly 
enhanced upregulation of GFP.  Similar results were observed when hrg-7 and sma-9 
were knocked down simultaneously.  To validate these results, we knocked down 
hrg-7 in IQ6011, IQ6311 dbl-1null mutants and IQ6312 GFP::DBL-1 
overexpressors.  While hrg-1 upregulation was dampened in dbl-1null worms 
compared to WT worms and worms overexpressing GFP::DBL-1, we observed 
significant GFP upregulation compared to worms fed control vector (Figure 5.8B).  
Next, we knocked down hrg-7 in these three strains and grew worms with or without 
200 µM heme.  Although hrg-7 knockdown resulted in a growth delay in IQ6011, this 
phenotype is dramatically enhanced in the dbl-1(nk3) background (Figure 5.9A, B).  
This growth delay can either be rescued partially by the DBL-1 transgene or fully 
rescued by heme supplementation.  Together, our data suggests that DBL-1 and 
HRG-7 function synergistically to regulate heme homeostasis.   
 
Discussion 
Our results reveal that intestinal heme transport is regulated by retrograde 
signaling from the neurons by DBL-1, which acts on the gut by regulating hrg-1 via 





















Figure 5.8: HRG-7 and DBl-1 independently regulate hrg-1::GFP  
A) GFP fluorescence (120 worms per treatment) quantified from IQ6015 (lin-
15b(nk3);Phrg-1::GFP)  fed dsRNA against control vector, dbl-1, sma-9, and hrg-7 at 
10 µM heme alone or in combination.  GFP was quantified using COPAS BioSort. 
P<0.01 (one way ANOVA).  B) GFP fluorescence (120 worms per treatment) 
quantified from of IQ6011, IQ6311 (Phrg-1::GFP ; dbl-1(nk3)), and IQ6312 (Phrg-
1::GFP Pdbl-1::GFP ; GFP) fed dsRNA against control vector or hrg-7 at 10 µM 





























Figure 5.9: HRG-7 and DBL-1 synergistically regulate heme homeostasis 
A) Representative images of IQ6011, IQ6311 (Phrg-1::GFP ; dbl-1(nk3)), and IQ6312 
(Phrg-1::GFP ; GFP::DBL-1;  dbl-1(nk3)) fed dsRNA against control vector or hrg-7 
with no added heme or 200 µM heme.  B) Quantification of worms from panel A 
(200-300 worms per treatment) using COPAS BioSort.  Graph is representative of 



































elegans at low heme, and this pathway functions in context with anterograde intestine 
to neuron signaling through HRG-7 to regulate systemic heme homeostasis.  
Depletion of either pathway results in a heme-dependent growth delay, but 
interrupting both pathways simultaneously results in a severe growth defect.  
Together, this suggests that the bidirectional signaling at the neural-intestinal axis in 
C. elegans is critical for ensuring the worm can physiologically respond to low 
nutritional heme (Figure 5.10).  
Our results indicate that hrg-7 is repressed by the DBL-1 /SMA-9 pathway, 
but DBL-1 may also have a role in HRG-7 protein stability that is independent of 
SMA-9 transcriptional regulation.  Conversely, HRG-7 does not appear to modulate 
DBL-1::GFP expression.  Importantly, depletion of DBL-1 and HRG-7 
simultaneously results in enhanced GFP and growth defects, indicating that, at least 
partially, the two proteins may function independent of each other to regulate heme 
homeostasis.   
In addition to understanding intertissue heme trafficking, the discovery of 
bidirectional signaling between the neurons and gut to regulate heme homeostasis 
may be informative as a paradigm for other micronutrients, an accepted concept for 
macronutrients such as glucose and lipids.  
Despite the advances in understanding systemic iron homeostasis, the role of 
the central nervous system in regulation of tissue iron availability and even regulation 
of iron levels within the central nervous system itself have not been well studied.  The 
central nervous system is an important mediator of metabolism and micronutrient 





















Figure 5.10: Systemic heme homeostasis is maintained by the neuron-gut axis 
In low heme conditions, HRG-7 is secreted from the intestine and localizes to sensory 
neurons to regulate hrg-1.  In conjunction, neurons can regulate hrg-1 by signaling to 
the intestine through DBL-1 /SMA-9.  Together, this bidirectional long-range 
signaling between intestine and neurons allow systemic heme homeostasis to be 
























shown that pica behavior, or a desire to eat non-food items, is linked to anemia and 
can be treated with iron supplementation [199-201].  This suggests that micronutrient 
deficiency influences foraging behavior.  It has also been shown that although the 
liver secretes hepcidin, signaling is initiated from the intestine [180].  We postulate 
























Chapter 6: Overall conclusions 
 
Heme is an iron containing tetrapyrrole that is required by all cells for 
incorporation into hemoproteins. The current paradigm states that cellular 
requirements for heme are fulfilled by the cell’s internal capacity to synthesize and 
degrade its own heme, i.e. cell autonomous regulation.  While evidence suggests that 
there is also cell non-autonomous regulation of cellular heme levels, the mechanisms 
involved in this latter form of regulation have been difficult to uncover due to 
interference from heme synthesis.  The goal of this project was to take advantage of 
the obligate heme auxotroph, C. elegans, to understand how tissues communicate to 
direct interorgan heme transport and maintain heme homeostasis on a systemic level.  
The major findings of these studies are outlined below. 
 
1) Knockdown of the intestinal heme exporter, mrp-5, results in upregulation of 
intestinal GFP in the heme sensor strain IQ6011 (Phrg-1::GFP).  This indicates a heme 
deficiency signal, despite the intestine accumulating heme in the intestine when mrp-
5 is depleted.  A genome-wide RNAi screen for modulators of heme homeostasis 
confirmed that >30% of genes were extraintestinal and that interorgan communication 
may contribute to the regulation of hrg-1. 
 
2) The genome-wide RNAi screen revealed two protease homologs, HRG-7 and 
HRG-8, as mediators of heme homeostasis.  The catalytic dyad of aspartic proteases, 




lacks both catalytic residues found in typical cysteine proteases.  Depletion by RNAi 
of either gene results in upregulation of GFP in IQ6011 and growth retardation 
phenotypes.  For hrg-7 RNAi the growth phenotype was reversible by heme 
supplementation but not for hrg-8 RNAi.  Additionally, HRG-7 and HRG-8 are both 
upregulated by low heme; HRG-7 is not expressed beyond 20 µM heme while HRG-8 
is expressed at ≥ 500 µM heme.  This suggests that HRG-7 is specifically required 
during heme limitation, while HRG-8 may have additional functions that may be 
independent of heme levels.   
 
3) Translational fusions show that HRG-7 and HRG-8 are secreted from intestine and 
then internalized into sensory neurons.  This suggests that the heme deficiency signal 
observed during HRG-7 and HRG-8 depletion could be a result of signaling from the 
target tissue.  In support of this, the intestinal heme deficiency signal is rescued by 
secretion of HRG-7 but not if HRG-7 is membrane tethered to the intestine.  These 
results predict the intestine responds to a HRG-7 dependent signal which originates 
from sensory neurons.  
 
4) The heme-response of hrg-7, hrg-1, and presumably mrp-5 is mediated by the 
HERE and surrounding GATA cis-elements.  HRG-1 and MRP-5 are involved in 
heme transport into and from the intestine, while HRG-7 seems to be necessary for 
the sensation of heme deficiency by extraintestinal tissues in response to intestinal 




conditions, extraintestinal tissues signal to the intestine through the HERE to 
upregulate genes required for heme acquisition for systemic homeostasis.   
 
5) HRG-7 is secretly shortly after translation and this secretion is essential for 
function.  Of the 45 known trafficking factors, we show that the snare protein SNAP-
29 and components of the vacuolar ATPase were required for HRG-7 secretion.  
Moreover, depletion of these genes by RNAi resulted in the accumulation of pro-
HRG-7.  Together, our data suggest that HRG-7 matures in an acidified compartment 
and is secreted after post-Golgi fusion events which rely on SNARE proteins.  It is 
possible some of the trafficking components are intestinal-specific, as we could not 
express functionally competent HRG-7 from muscle or neuron.  
  
6) HRG-7 propeptide removal requires acidic conditions typical of aspartic proteases.  
In most aspartic proteases this is often through autocatalysis which require the active 
site aspartic acids.  However, mutating D90 and D318 in HRG-7 did not prevent 
propeptide cleavage, indicating that a trans-acting protease may serve to cleave HRG-
7.  Surprisingly, this “inactive” HRG-7 could suppress the heme deficiency signal 
suggesting that either the predicted catalytic residues are not required for this function 
or there are other residues that may serve as active site ligands.  Whether HRG-7 is a 
protease at all in vivo or in vitro has not been determined. 
 
7) HRG-7 and HRG-8 localized to neurons, leading us to postulate that neurons could 




are refractory to RNAi in C. elegans, we generated a neuronal RNAi sensitive heme 
sensor strain, IQ6015, by introducing a lin-15b mutation into the heme sensor strain, 
IQ6011.  RNAi knockdown of 127 known morphogens and neuropeptides led to the 
discovery that of dbl-1, a bone morphogenic protein homolog, which is expressed in 
neurons.  Depletion of dbl-1 and sma-9, a transcription factor, recapitulate hrg-7 
deficiency by upregulating hrg-1.  
 
8) To gain a better understanding of how DBL-1 functions in heme homeostasis, we 
crossed either a dbl-1 null (nk3) or GFP::DBL-1 overexpressing worms into IQ6011.  
Worms lacking dbl-1 showed increased hrg-1, while those with overexpressed DBl-1 
showed hrg-1 even lower than WT worms.  This indicated that DBL-1 regulated hrg-
1 in a dose-dependent manner.  Worms lacking dbl-1 were growth retarded in low 
heme, a phenotype that was reversible in the presence of heme supplementation.  
Together, our data indicate that neurons, through DBL-1, are important mediators of 
systemic heme homeostasis.  
 
9) Microarray data and our RNAi experiments show that hrg-7 is upregulated when 
dbl-1 is depleted [197].  However, a dbl-1null mutant showed lower levels of mature 
HRG-7 and elevated amounts of pro-HRG-7, suggesting that dbl-1 mutants have a 
defect in posttranslational control of HRG-7 protein maturation.  SMA-9 does not 
play a role in this regulation of HRG-7 as RNAi depletion of sma-9 resulted in 




results posit that the DBL-1 / SMA-9 pathway is a genetic repressor of hrg-7, while 
DBL-1 may have an additional regulatory role on HRG-7 protein levels.  
 
10) Depletion of both dbl-1 and hrg-7 simultaneously show an enhanced synthetic 
effect; these worms are severely growth retarded, but growth is restored by heme 
supplementation.  These results reveal that neurons and the intestine act cooperatively 
through two secreted factors, HRG-7 and DBL-1, to maintain systemic heme 




Identification of HRG- 7 and HRG-8 substrates and interacting partners 
Our genetic assays suggest that HRG-7 does not require the canonical active site.  To 
evaluate whether HRG-7 has retained any protease activity, we are currently 
performing expression analyses of HRG-7-6xHIS in the methanotrophic yeast, Pichia 
pastoris.  Expression of secreted proteins in Pichia offers several advantages, 
including large scale protein purification and secretion directly into the media, 
bypassing cell lysis [202].  Once we purify sufficient amounts of HRG-7-6xHIS using 
a nickel column, we will utilize a peptide library to determine if HRG-7 has 
proteolytic activity and if so, its substrate preference [203].  If we can identify peptide 
substrates of HRG-7 in vitro, we can build a position weight matrix of cleavage 
specificity, and scan the C. elegans genome to find potential endogenous substrates.  




University of California, San Francisco.  If successful, we will knockdown candidates 
in IQ6011 and VH624 to evaluate which genes, when depleted, phenocopy hrg-7 
knockdown.  It is also possible that HRG-7 does not have any proteolytic activity but 
functions as either a morphogen or a heme chaperone.  We will use the purified HRG-
7 from Pichia in conjunction with hemin-agarose columns to analyze the heme-
binding capabilities of HRG-7.  To isolate an HRG-7 receptor or binding partners we 
will use Multi Dimensional Protein Identification Technology (MuDPIT).  MuDPIT 
couples immunoprecipitation with mass spectrometry analyses to identify the 
interacting partners of a bait protein.  This is being done in collaboration with the 
laboratory of Dr. James Wohlschlegel at the University of California, Los Angeles.  
We are currently utilizing this technique for both HRG-7-3xFLAG and HRG-8-
3xFLAG.  We have also generated a secreted negative control: HRG-3SP-mCherry-
3xFLAG.  The immunoprecipitation has been optimized and we have already 
obtained preliminary results (Figure 6.1A, B). We plan to repeat this experiment to 
identify a list of HRG-7 and HRG-8 candidates that repeatedly CO-IP with HRG-7 
and HRG-8 but not secreted mCherry.  Candidates can then be knocked down by 
RNAi in IQ6011 and VH624 to analyze if they can phenocopy HRG-7 or HRG-8 
depletion.  If candidates are validated by RNAi, reciprocal CO-IPs will be performed.  
Together, this will provide strong evidence for genuine interacting partners.  These 
experiments will be necessary in order to understand how HRG-7 and HRG-8 






Figure 6.1:  HRG-7 and HRG-8 MuDPIT reveals potential interacting partners 
A) Silver stain analyses of immunoprecipitation eluates.  Lysate from worms 
expressing HRG-7-3xFLAG, HRG-8-3x-FLAG, and HRG-3SP-3xFLAG were 
incubated overnight with anti-FLAG antibody conjugated to agarose beads.  The 
beads were washed and bound proteins were eluted off with 3xFLAG peptide.  
Eluates were run on an SDS-PAGE gel and analyzed by silver stain.  * indicates 
eluted target protein  B) Venn diagram depicting the number of unique and 








































































































HRG-7 and HRG-8 structure function analysis 
We have already shown that the predicted catalytic residues of HRG-7 are not 
required, at least, for intestinal regulation of hrg-1.  Moreover, HRG-8 altogether 
lacks obvious active site domains catalytic residues.  Therefore, we will perform a 
structure / function analyses of HRG-7 and HRG-8 to determine which residues are 
critical for function.  Within the active site pocket, there are conserved non-catalytic 
residues for both HRG-7 and HRG-8 (Figure 6.2A, B).  Although Hedgehog and 
HGF do not require the catalytic residues of the active site for function, they still 
require residues in the vicinity of the active site, suggesting that the binding pocket is 
important.  Therefore, we will mutate the conserved residues near the canonical 




.  These transgenes can be crossed into 
IQ6011 for functional evaluation of hrg-1 responsiveness.  Interestingly, HRG-7 has 
a unique insert of 40 amino acids that is predicted to form a cysteine rich alpha helix.  
In addition to protein stability, cysteines are important for metal coordination and 
redox sensing [204, 205].  We will delete this entire region to evaluate whether it is 
required for function.  To analyze whether HRG-7 and HRG-8 require autocatalytic 
activation for function, we will mutate the residues of the predicted propeptide 
cleavage site.         
   
 
Identification of downstream regulators of HRG-7 signaling  
HRG-7 and DBL-1 appear to regulate hrg-1 through separate pathways.  Therefore, 




Figure 6.2: Conserved residues of HRG-7 and HRG-8 
A) ClustalW alignment of HRG-7 with Cathepsin E.  Black shading indicates 
identical residues.  Gray shading indicates similar residues. Red asterisk indicate 
catalytic residues.  Green line indicates residues unique to HRG-7.  B) ClustalW 
alignment of HRG-8 with Cathepsin B.  Black shading indicates identical residues.  
Gray shading indicates similar residues. Red asterisk indicate catalytic residues 



















































































Identification of direct interactors through MuDPIT will facilitate the discovery of 
this pathway, but in conjunction with biochemical studies it would be useful to 
identify genes that are differentially regulated in the absence of HRG-7.  Currently 
there are no strains harboring deletions in the coding region of hrg-7, but CRISPR / 
Cas9 technology has made it possible to engineer deletions into specific regions of 
the genome with relative ease.  Therefore, we can generate a hrg-7 deletion strain in 
the lab and perform RNAseq to evaluate changes in the transcriptome in the absence 
of HRG-7.  We can genetically dissect pathways by knocking down candidate genes 
in conjunction with hrg-7 RNAi in IQ6015 (lin-15b (n744); Phrg-1::GFP). 
 
Functional dissection of HRG-7 and DBL-1 with tissue specific heme sensors  
Depletion of hrg-7, hrg-8, or dbl-1 results in a heme deficiency signal.  We 
hypothesize that sensory neurons can signal to the intestine when HRG-7 is depleted, 
but the pathway may be indirect.  Perhaps neurons integrate heme deficiency signals 
from other tissues prior to signaling to the intestine, the primary organ for heme 
uptake.  We also hypothesize that depletion of dbl-1 leads to SMA-9 depression in the 
intestine and therefore upregulation of hrg-1.  However, this does not explain why 
there is a heme-dependent phenotype associated loss of DBL-1.  Is heme availability 
compromised in specific tissues in the absence of HRG-7, HRG-8, and DBL-1?  The 
lab is currently developing tissue specific heme sensors that will assist in 
understanding the origin of heme deficiency signals in the absence of specific genes.  
These sensors will be expressed from tissues-specific promoters and based on the 




a heme moiety for enzymatic function.  Substrate can be added to lysate from these 
heme sensor strains grown under different RNAi conditions to evaluate specific 
tissues that might be heme deficient under a given condition.     
 
Significance 
Mammalian cells can regulate heme levels autonomously by coordinating 
heme synthesis and heme degradation.  Although there is mounting evidence that 
heme levels can be regulated through intertissue heme trafficking, this regulation is 
difficult to separate from cell autonomous regulation.  The lab has previously 
demonstrated that C. elegans is on obligate auxotroph, and must acquire dietary heme 
from the environment for incorporation into hemoproteins.  Consequently, all heme 
must pass through the intestine before being distributed to extracellular tissue such as 
neurons, muscle, hypodermis, and the germline.  Therefore, C. elegans is an ideal 
model in which to study intercellular heme trafficking.  We speculate that peripheral 
tissues must be able to communicate heme status to the intestine to ensure that the 
balance between adequate heme availability and toxicity is maintained.  In support of 
this hypothesis, depletion of the intestinal heme exporter MRP-5 simultaneously 
results in heme accumulation in the intestine and an intestinal heme deficiency signal.  
Additionally, analyses of candidate genes from our genome-wide screen indicated 
that knockdown of genes in peripheral tissues could result in an intestinal heme 
deficiency signal.  One such signaling factor is DBL-1, which is secreted by neurons 




bidirectional, as intestinal secreted HRG-7 and HRG-8 localizes to for maintaining 
proper heme homeostasis.   
Our findings are highly reminiscent of macronutrient signaling in mammals, 
which relies on the coordinated actions of the brain-gut axis, the pancreas, and the 
liver to maintain blood glucose levels.  Although the systemic coordination of 
micronutrients such as iron and copper is to be expected [206, 207], the contribution 
of the brain-gut axis to micronutrient homeostasis has not been established.  It has 
been proposed that the brain can regulate iron levels independently of systemic iron 
status because in models of hemochromatosis the brain remains unaffected [208].  
However, brain uptake of radioactive iron injected into mice was increased after 
being fed an iron deficient diet, and it is therefore likely that brain has an influence on 
the release of iron stores when iron deprived [63].  Additionally, pica behavior is 
associated with severe iron deficiency anemia and can be treated by iron 
supplementation, suggesting the brain can produce a satiety signal for iron [199-201].  
Remarkably, the intestine has been proposed to be the main regulator of systemic iron 
homeostasis through the iron induced expression of BMP6, which will results 
lowering of available iron, systemically [180].  Our discovery of a neuron-gut 
regulatory axis for heme homeostasis is novel and may be highly relevant to 
mammalian heme and iron metabolism.    
The majority of systemic iron will be utilized for heme.  Therefore, either 
cells rely completely on the aforementioned systemic iron regulation for heme 
synthesis, or separate pathways exist that allow cells to supplement heme synthesis 




and MRP5, and a portion of absorbed heme can be transported out of these cell types 
in toto [58-60].  Therefore, heme transporters are expressed in tissues that would 
allow uptake and intertissue transfer of heme.  Additionally, the brain expresses 
FLVCR1, MRP5, and HRG1 and neurons can take up exogenous heme, suggesting 
that heme can be imported and exported within the nervous system [13, 209, 210].    
Are such pathways relevant?  Interestingly, suboptimal neonatal iron levels are 
associated with higher placental LRP1 levels, suggesting that during limiting iron 
conditions there may be compensation by direct heme transport from mother to fetus 
[182].  This also hints at the possibility that the placenta can receive iron or heme 
dependent signals from the fetus or elsewhere.  Altogether, we speculated that these 
data suggest that there are likely pathways for direct heme transfer between tissues.  
These pathways may be important compensatory mechanisms during iron deficiency, 
heme synthesis deficiency, or pathogenesis.  Additionally, specific tissues may rely 
on heme uptake more than others.  Generation of tissue specific knockout animals and 
genetic chimeras will help uncouple heme synthesis from intercellular trafficking in 
mammalians.     
We have identified two secreted factors involved in long-range signaling that 
are essential for systemic heme homeostasis in C. elegans: HRG-7 and DBL-1.  Both 
proteins have potential homologs in humans.  The closest human homolog to HRG-7 
is cathepsin E, which is most highly expressed in early erythroid cells.  It has been 
proposed that cathepsin E is associated with inner leaflet of the plasma membrane in 
erythrocytes, but its function remains unclear [104].  Interestingly, erythrocyte 




role in the regulation of normal hematopoiesis [211, 212].  Additionally, it has 
recently been shown that erythroblast signaling influences systemic iron homeostasis 
in response to blood loss [213].  Taken together, it is possible that a portion of 
cathepsin E is secreted from these cells, or has a role in normal or pathological 
erythrocyte physiology.  Further studies, such as phenotype analyses of iron deficient 
CTSE
-/-
 mice will be required to understand the role of cathepsin E in mammalian 
iron / heme homeostasis.   
The bone morphogenic protein BMP6 has a well-defined role in mammalian 
iron homeostasis through the regulation of hepcidin [214].  Although BMP2, BMP4, 
and BMP9 are also upregulated in the intestine in response to iron and loss of BMP6, 
iron homeostasis is not restored likely because these BMPs are not potent regulators 
of hepcidin [180].  The downstream targets of intestinal, iron-induced BMP2, BMP4, 
and BMP9 have not been uncovered.  It is noteworthy that BMP2 and BMP4 are 
close homologs of DBL-1.  This opens up the intriguing possibility that a DBL-1 like 



















































Phrg-1::GFP::unc-54 3’ UTR; rol-6 marker  
Phrg-1::GFP::unc-54 3’ UTR; rol-6 marker  
rhIs13  
 
Pvha-6::HRG-8::3xFLAG::ICS::GFP::unc- 54; unc-119(+) 
 
 
Phrg-7::GFP::unc- 54 3’ UTR; unc-119(+)  
Phrg-7
mut::GFP::unc- 54 3’ UTR; unc-119(+) 
Phrg-8::GFP::unc- 54 3’ UTR ; unc-119(+) 













IQ7880 unc-119(ed3) Phrg-8::GFP::unc-54 3’UTR ; unc-119(+) 







Pvha-6:HRG-7::mCherry::unc-54 3’UTR; unc-119(+) 
Pvha-6:HRG-8::mCherry::unc-54 3’UTR; unc-119(+) 
This study 
This study 
IQ8333 unc-119(ed3) Pvha-6:HRG-3::mCherry::hrg-3 3’UTR; unc-119(+)  
IQ7711 unc-119(ed3) Pvha-6::HRG-7
PR::ICS::mCherry:: unc-54 3’UTR 
 Phrg-1::GFP::unc-54 3’UTR; unc-119(+) 
This study 
IQ7811 unc-119(ed3) Pvha-6::HRG-8
REC:ICS::mCherry::unc-54 3’UTR  
Phrg-1::GFP::unc-54 3’UTR; unc-119(+) 
This study 
IQ7812 unc-119(ed3) Pvha-6::HRG-8
REC:ICS::mCherry::unc-54 3’UTR  
Phrg-1::GFP::unc-54 3’UTR; unc-119(+) 
This study 







Pvha-6::HRG-8-3::XFLAG::ICS::GFP::unc- 54; unc-119(+) 
Pvha-6::iHRG-7
PR::ICS::mCherry:: unc-54 3’UTR; unc-
119(+) 
Pvha-6::HRG-7
PR::mCherry:: unc-54 3’UTR 






PR:ICS::mCherry:: unc-54 3’UTR, 
 Phrg-1::GFP:: unc-54 3’UTR; unc-119(+) 
This study 
IQ6015 lin-15b(n744) Phrg-1::GFP; unc-54 3’UTR This study 













zuIs178 [his-72(1kb 5' UTR)::his-72::SRPVAT::GFP::his-72 
 (1KB 3' UTR) + 5.7 kb XbaI - HindIII unc-119(+)]. 
 stIs10024 [pie-1::H2B::GFP::pie-1 3' UTR + unc-119(+)]. 
 stIs10698 [sma-9.k::H1-wCherry + unc-119(+)]. 
Pvha-6:HRG-7::mCherry::unc-54 3’UTR; unc-119(+) 







IQ6312 dbl-1(nk3) Phrg-1::GFP:: unc-54 3’UTR:: Pdbl-1::GFP::DBL-1  This study 
















Purpose Name Sequence 
hrg-7 promoter amplification 5'  PRM AAGCTTTCCAACGGTCAAACG 
 
3'  PRM GGATCCTGGCTTCCAACTTTTTTCC 
hrg-8 promoter amplification 5'  PRM GCC TTG TAA GAG CAG TTG AAG ACG  
 
3'  PRM AAGTTAAAAATTGAAATTTTATGAATTGATCAGGAAGAACC 
hrg-7 coding region 
amplification 5'  CDS ATGAAGACGTTTATTGCATTG 
 
3'  CDS GAGAACCTTTGCAAGGCCAAG 
hrg-8 coding region 
amplification 5'  CDS ATGCTCTTCATATTTCTATCATTTTTGTTACC 
 
3'  CDS CATCAGGATCCTTAGTTATGCTTTTCCGAATCTGGAAGCG 
hrg-7 3' UTR amplification 5'  3'UTR ATCCAATGAATCTCACATCAACG 
 
3'  3'UTR TTGATTGTAAAGTTTTTATTAAATTTTAGGGGGACAACTTTGTATAATAAAGTTG 
hrg-8 3' UTR amplification 5'  3'UTR CACTTATTCACTTTCAATTTACAAATTTTGTTTGAATTGC 
 
3' 3'UTR GGGGACAACTTTGTATAATAAAGTTGCAAGCTAGACGGCGATACCTGG 
dbl-1(nk3) genotyping 5' internal (C) CTTCATCGATTTGCCGGAAGATGTG 
 
3' internal (D) CAGTAGGCACACAGCAAGGTG 
 
5' flanking (A) CATGGACAAACATCGGGGA 
 
3' flanking (B) CGTGTACACAAATCTGTTCG 
 
5' GFP (E) CTGGGATTACACATGGCATGGATG 
 
3' dbl-1 (F) CGGATAATAGTGTCTGACCCAGTCGAC 
lin-15b(n744) genotyping 5' lin-15b(n744) CACAAACCTGGAGATCGCTCGAG 
 





HRG-3::mCherry and HRG-3-SP::mCherry do not localize to punctae in the 
anterior of the worm 
A) mCherry expression in the intestine, coelomocytes, and anterior of strain IQ8330 
(Pvha-6::HRG-3SP-mCherry).  In the anterior of the worm, mCherry is non-
specifically diffused throughout the pseudocoelomic fluid.  B) mCherry expression in 
the gonad and coelomocytes of IQ8333 (Pvha-6::HRG-3::mCherry).  No mCherry is 


























































HRG-7::mCherry and HRG-8::mCherry do not colocalize with GFP expressed 
in hypodermis, pharyngeal muscle, or body wall muscle 
Representative images of expression of tissue specific GFP / YFP markers Pceh-
22::GFP (pharyngeal muscle), Pdpy-7::YFP (hypodermis), and Pmyo-2::GFP (body wall 
muscle) crossed into strains IQ7670 (Pvha-6::HRG-7::mCherry) and IQ7680 (Pvha-
6::HRG-8::mCherry).* indicates body wall muscle (BWM). Arrow indicates 
pharyngeal muscle (PM).  Arrowhead indicates hypodermis (H).  Images are 63 x, 

































































































































Competent HRG-7 and HRG-8 cannot be expressed from muscle or neurons 
A) Representative image of GFP fluorescence in worms expressing Phrg-1::GFP alone 




:ICS::mCherry and fed 




at 10 µM heme.  B) Immunoblot 







:ICS::mCherry or WT worms fed dsRNA 
against, hrg-7
300bp
.   Membranes were probed with polyclonal anti-HRG-7 antibody 
and then incubated with HRP-conjugated anti-rabbit secondary antibody. * indicates 
pro-HRG-7.  + indicates mature HRG-7.  C) Representative image of GFP 






































































HRG-7 and HRG-8 cannot be tethered to the intestinal basolateral membrane 
A) mCherry expression in the intestine of a worm expressing Pvha-6::HRG-
7
PR
::mCherry-TAC  B) mCherry expression in the coelomocytes of a worm 
expressing (Pvha-6::HRG-8
REC
::mCherry-GPI). Arrow indicates coelomocyte. C) 
mCherry expression in the intestine of a worm expressing Pvha-6::HRG-
8
REC
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